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Summary 
XPD is a 5‘-3‘ helicase of the superfamily 2. As part of the transcription factor IIH it 
functions in transcription initiation and nucleotide excision repair. This work focus 
on the role of XPD in nucleotide excision repair. NER is a DNA repair pathway 
unique for its broad substrate range. In placental mammals NER is the only repair 
mechanism able to remove lesions induced by UV-light. NER can be divided into 
four different steps that are conserved between pro- and eukaryotes. Step 1 
consists of the initial damage recognition, during step 2 the putative damage is 
verified, in step 3 the verified damage is excised and in the 4th and final step the 
resulting gap in the DNA is refilled. XPD was shown to be involved in the damage 
verification step. 
It was possible to solve the first apo XPD structure by a MAD approach using only 
the endogenous iron from the iron sulfur cluster. Based on the apo XPD structure 
several questions arise: where is DNA bound? Where is DNA separated? How is 
damage verification achieved? What is the role of the FeS cluster? These 
questions were addressed in this work. Hypothesis driven structure based 
functional mutagenesis was employed and combined with detailed biochemical 
characterization of the variants. The variants were analyzed by thermal unfolding 
studies to exclude the possibility that the overall stability could be affected by the 
point mutation. DNA binding assays, ATPase assays and helicase assays were 
performed to delineate amino acid residues important for DNA binding, helicase 
activity and damage recognition. A structure of XPD containing a four base pair 
DNA fragment was solved by molecular replacement. This structure displays the 
polarity of the translocated strand with respect to the helicase framework. 
Moreover the properties of the FeS cluster were studied by electron paramagnetic 
resonance to get insights into the role of the FeS cluster. Furthermore XPD from 
Ferroplasma acidarmanus was investigated since it was shown that it is stalled at 
CPD containing lesions. The data provide the first detailed insight into the 
translocation mechanism of a SF2B helicase and reveal how polarity is achieved. 
This provides a basis for further anlayses understanding the combined action of 
the helicase and the 4Fe4S cluster to accomplish damage verification within the 
NERcascade. 
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Zusammenfassung 
XPD ist eine 5‘-3‘ Helicase der Superfamilie 2. Als Untereinheit des 
Transkriptionsfaktors IIH ist XPD in Transkriptionsinitiation und Nucleotid-
Exzisions-Reparatur involviert. Diese Arbeit fokusiert auf die Rolle von XPD in der 
NER. NER ist ein DNA Reparatur Weg der bekannt ist für seine breite 
Substratspezifität. In Säugetieren ist NER der einzige Reparaturmechanismus, der 
fähig ist Läsionen zu reparieren, die durch UV Strahlung induziert werden. NER 
kann man in vier unterschiedliche Schritte aufteilen die zwischen Pro- und 
Eukaryoten konserviert sind. Schritt 1 besteht aus der initialen 
Schadenserkennung, während des zweiten Schrittes wird der mögliche Schaden 
verifiziert, im dritten Schritt wird der verifizierte Schaden ausgeschnitten und im 
vierten und letzten Schritt wird die resultierende Lücke in der DNA geschlossen. 
Es wurde gezeigt, dass XPD in die Schadensverifizierung involviert ist. 
Ein MAD Versuch, bei dem nur das endogene Eisen des Eisen-Schwefel-Clusters 
verwendet wurde ermöglichte die Strukturlösung der ersten apo XPD Struktur. 
Basierend auf der Struktur ergeben sich verschiedene Fragen: wo wird DNA 
gebunden? Wo wird DNA aufgetrennt? Wie wird Schadenserkennung ermöglicht? 
Was ist die Rolle des Eisen-Schwefel-Clusters? Diese Fragen werden in dieser 
Arbeit angesprochen. Strukturbasierte funktionelle Mutagenesestudien, die auf 
Hypothesen basiert sind, wurden angewendet und mit einer detailierten 
biochemischen Charakterizierung der Varianten kombiniert. Die Varianten wurden 
mittels thermischen Entfaltungsstudien analysiert, um die Möglichkeit 
auszuschliessen, dass die Stabilität durch die Punktmutation betroffen ist. DNA-
Bindungs- Assays, ATPase Assays und Helikase Assays wurden durchgeführt um 
Aminosäurereste zu identifizieren, die für DNA Bindung, Helikase Aktivität und 
Schadenserkennung wichtig sind. Eine Struktur von XPD, die ein DNA Fragment 
mit vier Basen enthält, wurde mittels Molekularem Ersatz gelöst. Diese Struktur 
zeigt die Polarität des translozierenden DNA- Stranges im Verhältnis zu der 
Helikasestruktur auf. Desweiteren wurden die Eigenschaften des FeS Clusters 
mittels paramagnetischen Elektronenresonanz Studien untersucht, um Einblicke in 
die Rolle des FeS Clusters zu bekommen. Ausserdem wurde XPD aus 
Ferroplasma acidarmanus erforscht, da gezeigt wurde, dass es an CPD 
enthaltenden Läsionen hängen bleibt. Diese Daten stellen die ersten detailierten 
Einblicke in den Translokationsmechanismus einer SF2B Helikase dar und zeigen 
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wie Polarität erzielt wird. Das ist eine Basis für weitere Analysen, um die 
kombinierte Aktion von Helikase und dem 4Fe4S Cluster zu verstehen, die zur 
Schadenserkennung in der NER Kaskade führt. 
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1 Introduction 
The DNA of each cell is endangered by a variety of modifications arising 
spontaneously by replication errors, endogenously by reactive metabolites, or 
exogenously after exposure to environmental mutagens or ultraviolet (UV) light. 
Damages occur quite frequently at a rate of about 200,000 damages per cell per 
day. If lesions in DNA cannot be eliminated, a cell may undergo apoptosis or will 
accumulate mutations and transform into a potentially cancerous cell that might 
proliferate into a tumor(Sarasin 2003). 
To deal with all the different types of DNA lesions different DNA repair pathways 
evolved in all kingdoms of life. DNA repair is commonly dived into five major 
pathways: direct damage reversal, base excision repair (BER), mismatch repair, 
double strand break repair and nucleotide excision repair (NER). NER is one of 
the most versatile DNA repair systems. It can be subdivided into two distinct 
subpathways: global genome repair (GGR), which can detect and remove lesions 
throughout the genome and relies on a dedicated set of proteins, and 
transcription-coupled repair (TCR), which ensures faster repair of many lesions 
when located on the transcribed strand of actively transcribed genes (Figure 
1.2)(Guo et al. 2010). TCR is initiated by a RNA polymerase stalled at a lesion 
(Svejstrup 2002), (Brueckner et al. 2007), (Hanawalt and Spivak 2008). A key 
player in eukaryotic NER is transcription factor IIH (TFIIH) which functions in NER 
and transcription(Bradsher et al. 2000). 
 
1.1 Lesions addressed by nucleotide excision repair 
NER is a particularly intriguing DNA repair pathway because of its extraordinarily 
wide substrate specificity; it has the ability to recognize and repair a large number 
of structurally unrelated lesions(Sancar 1994), (Sancar et al. 1996), such as DNA 
damage formed upon exposure to the UV radiation from sunlight and numerous 
bulky DNA adducts induced by mutagenic chemicals from the environment or by 
cytotoxic drugs used in chemotherapy as reviewed in(Gillet and Scharer 2006)and 
(Nouspikel 2009). 
NER is also involved in the repair of crosslinking agents. These chemicals can 
form two distinct bonds with DNA, either on the same strand (intrastrand 
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crosslinks) or across both strands (interstrand crosslinks)(Trimmer and Essigmann 
1999). For the repair of interstrand crosslinks a combination of NER with 
translesion synthesis and/or homologous recombination is necessary, because 
NER requires an intact strand to serve as template to repair the other strand 
(Kuraoka et al. 2000). Classical examples for crosslinking agents are cis-dichloro-
diaminoplatin (cisplatin) (Figure 1.1), nitrogen mustards and psoralens (Trimmer 
and Essigmann 1999), (Hearst et al. 1984). 
 
Figure 1.1: DNA lesions repaired by NER(GG cisplatin lesion reprinted by permission from 
Macmillan Publishers Ltd: Nature Structural and Molecular Biology(Damsma et al. 2007), ©2007 
Other chemicals handled by NER are for example benzo[a]pyrene (cigarette 
smoke) (Figure 1), aromatic amines, aflatoxin and nitrosamines (Wogan et al. 
2004). These chemicals share a common property, they are present in the 
environment in a relatively harmless form. These so-called proximate carcinogens 
are absorbed with food (nitrosamines, aflatoxin) or air (benzo[a]pyrenes) and then 
activated by cellular metabolism to highly reactive species. These ‘ultimate 
carcinogens’ are highly reactive and have a strong tendency to form bulky adducts 
on DNA (Wogan et al. 2004).  
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Another class of lesions which is repaired by NER is UV-induced lesions. In 
placental mammals NER is the only error-free DNA repair mechanism which can 
repair these lesions (Hoeijmakers 2009), (Friedberg et al. 2006), (Reardon and 
Sancar 2003). Short-wavelength UV light can cause the formation of covalent 
bonds between two adjacent pyrimidines on the same strand. Cyclobutane 
pyrimidine dimers (CPDs) and (6-4)pyrimidine-pyrimidone photoproducts [(6-
4)PPs] (Figure 1.1) are the two main UV-induced lesions (Pfeifer 1997), 
(Nouspikel 2009). 
Oxidized bases are generally repaired by base excision repair; however several 
types of oxidative damage are recognized by NER. For example cyclopurines 
(Brooks 2007) and malondialdehyde formed DNA adducts (Johnson et al. 1997). 
 
1.2 Molecular mechanism of eukaryotic NER 
The mechanism of NER has been reconstitued in vitro (Aboussekhra et al. 1995), 
(Mu et al. 1995) and is now better understood. NER consists of several 
consecutive steps: first lesion sensing, second opening of a bubble, third incision 
of the damaged strand, as a fourth step displacement of the lesion-containing 
oligonucleotide, finally gap filling and ligation (Figure 1.2)(Nouspikel 2009). 
There are two requirements that NER takes place(Sugasawa 2001). First there 
must be a distortion in the structure of the double helix and second there must be 
a chemical modification in the DNA. In mammalian GGR the distortion-sensing 
complex consists of the subunits XPC, HR23B and centrin 2 (Araki et al. 2001). 
The XPC/HR23B heterodimer opens the DNA locally (Min and Pavletich 2007). 
Upon DNA damage XPC is polyubiquitinated which increases XPC’s affinity for 
DNA (Sugasawa et al. 2005).Centrin 2 stabilizes the complex and improves NER 
activity, but its presence is not strictly required for NER (Araki et al. 2001). Not all 
lesions cause an equal distortion of the double-helix. (6-4)PPs for example lead to 
a strong kink in the DNA making them very good NER substrates, whereas CPDs  
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Figure 1.2: Model of the eukaryotic NER pathway.
Cell(Guo et al., 2010), ©2010) 
XPC-HR23B complex, UV-lesions can 
TFIIH. The ten subunit containing transcription factor TFIIH is recruited to locally unwind the DNA 
by the concerted activity of XPB and XPD. The two endonucleases XPG and 
dual incision to remove the damaged oligonucleotide. Finally DNA synthesis takes place with the 
combined activities of DNA polymerases 
4
(Reprinted by permission from Elsevier, 
DNA lesions (indicated by a red star) are initially detected by the 
alternatively be detected by the DDB-complex which recruits 
δ and ε or PCNA. Ligase III seals the nick.
 
XPF-ERCC1 ensure 
 In TCR RNA-
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Polymerase II is stalled at a lesion which leads to the recruitment of CSA, CSB and TFIIHthe 
following steps are the same as for GGR (Guo et al., 2010). 
just lead to a modest distortion and are therefore poor substrates for NER (Kim et 
al., 1995). (6-4)PPs are recognized by the XPC complex alone, but for efficient 
repair of CPDs the DDB complex is needed. The DDB complex is a damaged 
DNA-binding heterodimer consisting of DDB1 and DDB2 (XPE). This complex has 
a high affinity for DNA damage, such as CPDs and (6-4)PPs (Wittschieben et al. 
2005), (Payne and Chu 1994). It was proposed that DDB induces a kink in the 
DNA upon binding to a lesion which allows the recruitment of the XPC complex 
(Tang and Chu 2002), (Nouspikel 2009). 
In transcription-coupled repair the initial detection step is achieved differently. RNA 
polymerase II is stalled at a lesion during transcription which is a strong signal for 
apoptosis(Brueckner et al. 2007), (Hanawalt and Spivak 2008). CSA and CSB 
(Cockayne’s syndrome complementation group A and B) are then recruited as well 
as TFIIH to perform NER (Laine and Egly 2006), (Laine et al. 2006), (van Hoffen et 
al. 1993). 
The next step in NER is the opening of a bubble around the lesion by the 
transcription factor TFIIH. TFIIH is a 10 subunit containing complex which 
functions in NER and in transcription(Bradsher et al. 2000). TFIIH contains the two 
helicases XPB and XPD, which are of opposite polarity. XPD, a 5’-3’ helicase, 
plays a critical role in NER by opening a bubble around the lesion (Winkler et al. 
2000). XPB, a 3’-5’helicase, is also required for this function, but in the repair 
process it is XPB’s ATPase activity which is necessary, not its helicase activity 
(Coin et al. 2007). XPB hook up to the complex whereas XPD unwinds the 
DNA(Winkler et al. 2000), (Coin et al. 2007). XPB, XPD and five other subunits 
(p62, p52, p44, p34 and TTD-A) form a ring-shaped structure with a central cavity, 
which could accommodate double-stranded DNA(Schultz et al. 2000). This is the 
core of TFIIH to which the cyclin-activated kinase (CAK) complex (cyclin H, cdk7, 
MAT1) is attached (Chang and Kornberg 2000), (Schultz et al. 2000). MAT1 
mediates the interaction between the CAK complex and the core of TFIIH (Busso 
et al. 2000). The CAK complex works as a phosphorylation cascade: cyclin H is 
phosphorylated by external kinases and phosphorylates Cdk7, which (when it is 
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part of TFIIH) phosphorylates the large subunit of RNA polymerase II(Nouspikel 
2009). This allows RNA polymerase II to enter the elongation mode. 
After TFIIH the XPA protein complex is recruited (Volker et al. 2001) which 
removes the XPC/HR23Bcomplex in this process (Hey et al. 2002) and catalyzes 
the detachment of CAK from the core (Coin et al. 2008). XPA binds DNA with a 
slight preference for damaged DNA (Jones and Wood 1993)and is associated with 
the three subunits of the RPA heterotrimer(Matsuda et al. 1995). However, the 
exact role of the XPA complex is still not clear. A possible role for the XPA 
complex could be the identification of the strand that carries the lesion (Sugasawa 
et al. 1998). It is also possible that this discrimination function is accomplished by 
TFIIH (Wood 1999). It was shown that translocation of the yeast homologue Rad3 
is stalled at sites of damage in vivo(Naegeli et al. 1993).In addition it was shown 
that XPD from Ferroplasma acidarmanus(faXPD) is stalled at lesions containing a 
CPD (Mathieu et al. 2010) indicating a role for XPD in damage recognition.  
The next step in NER is the incision of the damaged strand at both sides of the 
bubble after the dissociation of the CAK complex from the TFIIH core. The XPG 
endonuclease carries out the 3’cut (O'Donovan et al. 1994), whereas the 5’cut is 
performed by the XPF-ERCC1 heterodimer (Mu et al. 1996) which is recruited to 
the NER incision complex by XPA(Park and Sancar 1994), (Li et al. 1994), (Li et 
al. 1995),(Saijo et al. 1996). The presence of XPG is necessary for XPF-ERCC1 to 
incise the other end of the bubble, but the incision by XPG does not essentially 
come first (Wakasugi et al. 1997), (Gillet and Scharer 2006). As for the XPF-
ERCC1 complex, it is XPF that harbors the endonuclease activity (Enzlin and 
Scharer 2002). The role of ERCC1 in the complex is not clear, aside from the fact 
that it stabilizes XPF (Houtsmuller et al. 1999). 
The last steps in NER are gap filling and ligation. The fragment excised by 
mammalian NER is about 24-32 nucleotides in length, depending on the lesion 
(Moggs et al. 1996), (Matsunaga et al. 1995), (Svoboda et al. 1993). The excised 
lesion is located closer to the 3’side of the removed DNA as to the 5’ side 
indicating a asymmetric pattern for incision(Moggs et al. 1996). The resulting gap 
is filled by either of the replicative DNA polymerases delta or epsilon (Popanda et 
al., 1992), associated with the ‘sliding clamp’ PCNA (Shivji et al. 1992), (Nichols 
and Sancar 1992). Recent data indicate that it is mostly ligase III, together with its 
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partner XRCC1, which seals the nick 
thought ligase I (Nocentini 1999
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(Boal et al. 2005). Alternatively the FeS cluster might function in redox sensing 
(White 2009). Finally the FeS cluster could have a purely structural role, stabilizing 
the FeS domain where the DNA duplex is separated during helicase function 
(Pugh et al. 2008). It was furthermore shown for XPD from Ferroplasma 
acidarmanus that the single-stranded DNA binding protein RPA2 stimulates DNA 
unwinding by the faXPD helicase (Pugh et al. 2008). It was suggested that duplex 
melting by a cognate ssDNA-binding protein coordinated with translocation by a 
helicase may represent a common strategy for duplex unwinding by the Rad3 
family of helicases (Pugh et al. 2008). Distance-dependent fluorescence 
quenching by the iron-sulfur cluster of archaeal XPD revealed that the two cognate 
ssDNA-binding proteins differentially affect XPD translocation. RPA1 competes 
with XPD for ssDNA access whereas RPA2 does not interfere with XPD-ssDNA 
binding but markedly slowed down XPD translocation (Honda et al. 2009). It was 
proposed that translocation on a protein-coated DNA lattice may represent a 
generalized feature used by Rad3 family helicases. There are two possible 
mechanism for these helicases, XPD in particular, to bypass ssDNA-binding 
proteins: XPD can translocate over the bound ssDNA-binding protein or the SSB 
protein dissociates ahead of the translocating XPD (Honda et al. 2009), (Spies and 
Ha 2010).  
In eukaryotes XPD functions as part of the TFIIH complex whereas in archaea 
XPD is a monomer in solution and so far no stable interactions with other protein 
partners have been reported (Rouillon and White 2011). XPD is an essential 
structural component of TFIIH and bridges the TFIIH core subunits with the CAK 
complex (Reardon et al. 1996) by its interaction with p44 and MAT1. Once TFIIH is 
bound to the damaged DNA, the interaction between p44 and XPD leads to the 
stimulation of XPDs helicase activity (Coin et al. 1998), (Dubaele et al. 2003), 
(Egly and Coin 2011). The stimulation of XPD helicase activity by p44 allows the 
unwinding of the DNA around the damage, a prerequisite for the dual incision 
executed by XPG and ERCC1-XPF. The helicase activity of XPD is essential for 
NER, but dispensable for transcription initiation (Tirode et al. 1999). Mutations in 
the XPD gene lead to three severe diseases: xeroderma pigmentosum, Cockayne 
Syndrome and trichothiodystrophy, indicating the importance of a fully functional 
XPD (Lehmann 2001). The mutations found in the 3’-end of XPD represent more 
than 80 % of the mutations found in XP-D patients and hinder the XPD-p44 
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interaction (Coin et al. 1998), (Dubaele et al. 2003), (Egly and Coin 2011). 
Recently it was discovered that XPD also exists in TFIIH-free complexes and plays 
roles in other processes than transcription and repair. As part of the MMXD 
complex XPD is required for proper chromosome segregation (Ito et al. 2010). 
XPD can also form a complex with CAK which functions as a control for cell cycle 
progression (Cameroni et al. 2010). 
A highly debated question is whether or not XPD is responsible for the damage 
verification in the NER pathway and if it acts alone or with other factors such as 
XPA. It was shown for the yeast homolog Rad3 that translocation is stalled at sites 
of damage in vivo(Naegeli et al. 1993). Moreover the enzymatic activity of XPD 
promotes its own anchoring to damaged DNA in living cells, thus supporting the 
conclusion that XPD is directly responsible for the predicted lesion verification step 
(Mathieu et al. 2010). However it was shown recently that XPD from Sulfolobus 
acidocaldarius (saXPD) is not stalled in the presence of DNA lesions which are 
removed by the NER pathway (Rudolf et al. 2010),whereas XPD from 
Ferroplasma acidarmanus(faXPD) is stalled at a CPD lesion during 5’-3’movement 
and forms a tight complex with DNA (Mathieu et al. 2010).Furthermore faXPD’s 
ATPase activity is stimulated in the presence of a CPD containing oligonucleotide 
(Mathieu et al. 2010).  
 
1.4 Diseases caused by mutations in XPD 
There are several genetic diseases linked to mutations in genes involved in GGR 
and TCR, namely xeroderma pigmentosum (XP), Cockayne’s syndrome (CS) and 
trichthiodystrophy (TTD)(Lehmann 2001)(Figure 1.4). 
XP is a rare autosomal recessive genetic disorder and was the first DNA-repair 
disorder to be identified (Von Hebra 1874). XP is characterized by skin atrophy, 
pigmentation abnormalities, a more than 2000-fold increased incidence of skin 
cancer and neurological abnormalities caused by premature neuronal death 
(Kraemer et al. 1987), (Rapin et al. 2000). XP results from a deficiency in NER at 
the global genomic level (Cleaver 1968), (Setlow et al. 1969). XPD-mutations 
leading to XP are located at the C-terminus of the protein, i.e. R683W and R683Q, 
or in the helicase motifs, for example G47R, T76A and D234N (Figure 4). However 
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XP can also be caused by mutations in other genes. There are8 complementation 
groups in XP: XP-A through XP
(Setlow et al. 1969), (Masutani et al. 1999
 
Figure 1.4: Diseases caused by mutations in XPD. 
Distribution of mutations in XP
bar with the seven helicase doma
in different patients, with the number of symbols indicating the number of times that the particular 
allele has been identified in patients (i.e., two symbols for homozygotes, one for compoun
heterozygotes). (Green circles) XP,
by permission fromCSHL Press, 
CS was reported by Edward Alfred Cockayne in 
multisystem disorder characterized by mental retardation, microcephaly, retinal 
and skeletal abnormalities and severe cachectic dwarfism 
1992), (Rapin et al. 2000
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symptoms observed in CS, the CS phenotype cannot be explained by a defect in 
TCR alone. However, it has been suggested that CS cells have a mild impairment 
in transcription on a more global level (Gillet and Scharer 2006) , (van Gool et al. 
1997). Mutations in XPD which cause XP/CS are found in the C-terminal part of 
the protein, for example G575R and G602D (Figure 1.4). 
TTD is characterized by sulfur-deficient brittle hair, caused by a greatly reduced 
content of cysteine-rich matrix proteins in the hairshafts (Gillespie and Marshall 
1983). Other symptoms are mental retardation, unusual facies, ichthyotic skin and 
a reduced stature (Itin et al. 2001), (Itin and Pittelkow 1990). Many, but not all 
patients are sensitive to sunlight. However there are no reports on unusual 
pigmentation changes or cancer in TTD patients (Lehmann 2001). TTD is now 
known to correlate with mutations in genes involved in NER, namely XPB, XPD 
and TTDA which are subunits of TFIIH (Weeda et al. 1997), (Stefanini et al. 1986), 
(Giglia-Mari et al. 2004). Given that TFIIH operates in transcription as well as in 
NER it was suggested that TTD may result from a subtle defect in transcription, 
rather than from a deficiency in NER(Bootsma and Hoeijmakers 1993) , 
(Vermeulen et al. 1994). Mutations leading to TTD are mostly found at the C-
Terminus of XPD with the exception of R112H and C259Y which are located in the 
N-terminal part (Figure 1.4). 
 
1.5 Iron-sulfur clusters 
In contemporary organisms, iron-sulfur (Fe-S) clusters are perhaps the most 
abundant and the most diversely employed enzymatic cofactors (Imlay 2006). The 
simplest FeS centre is comprised of a single iron atom liganded within a 
polypeptide by four cysteine residues. The more common FeS clusters have two, 
three or four iron atoms coordinated to polypeptide residues and bridged by 
inorganic sulfide (Figure 1.5)(Imlay 2006). 
These clusters can fulfill different roles, for example iron storage, structural roles, 
electron transport(Boal et al. 2005), substrate binding (Lauble et al. 1992) and 
regulation of gene expression (Kiley and Beinert 2003), (Flint and Allen 1996), 
(Imlay 2006). 
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Figure 1.5: Structure of common iron-sulfur centers and clusters. (A) Rubredoxin-style iron 
centre. (B) [2Fe-2S] cluster. (C) [3Fe-4S] cluster. (D) [4Fe-4S] cluster. Reprinted by permission 
from John Wiley & Sons, Inc.: Molecular Microbiology(Imlay, 2006) ©2006 
Recently, in several DNA binding proteins FeS clusters were identified, for 
example in eukaryotic Primase (Vaithiyalingam et al. 2010), (Weiner et al. 2007), 
(Klinge et al. 2007)in the helicases DinG (Ren et al. 2009), XPD and FancJ 
(Rudolf et al. 2006) as well as in DNA-glycosylases (Hinks et al. 2002) and in 
archaeal RNA polymerase (Hirata et al. 2008), which raises the question of the 
role of the iron sulfur cluster in these proteins. 
MutY is a DNA-glycosylase which contains a 4Fe-4S cluster and functions in base 
excision repair. The data from intensive studies indicate that the region supported 
by the cluster is intimately involved in DNA binding (Guan et al. 1998), and that 
such binding interactions impact catalysis of base removal (Porello et al. 1998), 
(Chepanoske et al. 2000). Recent evidence has also established that binding of 
MutY to DNA facilitates oxidation of the [4Fe-4S]2+ cluster to the [4Fe-4S]3+ form. 
Based on this DNA mediated redox behavior, it has been suggested that this 
property may be used to enhance the activity of these enzymes by facilitating 
damaged DNA location (Lukianova and David 2005), (Boon et al. 2003). 
 
1.6 Archaeal homologs: a model for eukaryotic NER 
Archaea were, besides prokaryotes and eukaryotes, identified as the third 
kingdom of life (Woese and Fox 1977). Based on a ribosomal phylogenetic 
analysis, archaea are subdivided into two groups, the euryarchaea and the 
crenarchaea (Cox et al. 2008). Because of the advantages archaeal proteins have 
and because of the high sequence homology to human XPD we used the archaea 
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Thermoplasma acidophilum as a model organism. Until its genome was 
sequenced Thermoplasma was thought to be a eukaryotic organism (Ruepp et al. 
2000).  
Table 1.1: Distribution of selected DNA repair proteins in sequenced archaeal genomes. 
 
Crenarchaea are at the top, followed by euryarchaeal species, ranked by growth temperature. The 
numbers show the presence and number of each repair gene. A circle indicates that bacterial 
repair genes are present in archaeal genomes (Reprinted by permission fromElsevier: Current 
Opinion in Microbiology(Kelman & White, 2005), ©2005. 
Especially for hyperthermophilic archaea the question arises which mechanisms 
are used to maintain genomic stability (Grogan 2000), (Grogan 2004). It is still an 
open question whether or not there is NER in archaea. The bacterial UvrABC 
machinery is only found in certain mesophilic archaea (Table 1.1), these instances 
probably reflect a lateral gene transfer event from a bacterial donor (Grogan 
2000). For the majority of archaea a different pathway must be assumed. Most 
archaea contain several homologues of the eukaryotic NER nucleases 
XPF/ERCC1 and Fen1 and the helicases XPB and XPD (Table 1.1), raising the 
possibility that a eukaryal-type NER pathway is functional in archaea (Kelman and 
White 2005). However the NER proteins XPA and XPC are not present. 
Furthermore several archaeal genomes lack one or more of the eukaryal-type 
NER enzymes, for example Methanopyrus kandleri and 
Methanothermobacterthermoautotrophicus lack XPB and XPD. The presence of 
different NER proteins does not guarantee NER functionality of the present 
enzymes (Rouillon and White 2011). In addition all of these proteins can perform 
alternative functions in vivo.  
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Furthermore there is no published evidence for a NER-type patch repair pathway 
in archaea other than in Methanothermobacterthermautotrophicus(Ogrunc et al. 
1998), which contains a complete set of UvrABC genes. Thermoplasma 
acidophilum lacks the UvrABC genes as well as XPF (Table 1.1), however it 
contains a clear homologue of XPD. XPD from Sulfolobus acidocaldarius was 
shown to be a monomer in solution (Rudolf et al. 2006), but lacking a known 
interaction partner the function of archaeal XPD remains unclear so far(Kelman 
and White 2005).Other NER proteins also fulfill different roles as in the NER 
pathway. XPF for example moonlights in several different repair pathways. In 
mammals XPF is involved in single strand annealing and gene conversion (Al-
Minawi et al. 2008). Furthermore XPF limits L1 retrotransposition (Gasior et al. 
2008). Fen1 on the other hand is involved in long patch BER and Okazaki 
fragment processing (Kelman and White 2005). These observations demonstrate 
multi-cellular functions for NER proteins indicating that these proteins not 
necessary fulfill NER roles. 
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2 Materials 
2.1 Chemicals 
If not noted differently, all chemicals and solutions were purchased from Carl Roth 
(Karlsruhe), Sigma Aldrich (Seelze), Fluka (Neu-Ulm), Hampton Research 
(Laguna Hills, USA), or Applichem (Darmstadt). All chemicals were of analytical 
grade or better, the chemicals used for crystallization were of the highest available 
purity. 
2.2 Equipment, instrumentation and expendable materials 
Table 2.1: Instruments used in this work 
Equipment 
 
Autoclave Systec V-150 Systec 
Bacteria shaker ISF-1-W Kühner 
Balances 
XS 105 Dual Range 
XS 6002S Dual Range 
 
Mettler Toledo 
 
Bio-Photometer Eppendorf 
Camera AxioCam MRC Zeiss 
CD-Spectropolarimeter J-810 Jasco 
Cell disruptor Constant Systems 
Centrifuges 
Centrifuge 5415 D 
Centrifuge 5810 R 
Avanti J-26 XP 
 
Eppendorf 
Eppendorf 
Beckmann Coulter 
Chromatography-system Äkta purifier GE Healthcare 
Columns for affinitychromatography 
Econo-Column 1,5 x 15 cm 
Econo-Column 2,5 x 20 cm  
 
Biorad 
Columnmaterial for affinitychromatography 
Ni-NTA Agarose 
 
Invitrogen 
Cryo loop Hampton Research 
Flouromax4 fluorescence spectrometer Horiba Jobin Yvon 
Gelelectophoresis Mini-Protean 3-cell Biorad 
Gelfiltration HiLoad 26/60 Superdex 200 prep grade GE Healthcare 
HoneyBee 963 crystallization robot Zinser Analytik 
Illumination table Roth 
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Incubator Heraeus 
Lightsource KL 2500 LCD Zeiss 
Lissy liquid handling robot Zinser Analytik 
Magnetic stirrer MR 3002 Heidolph 
Microscope Zeiss 
Nanodrop ND 1000 Spectrophotometer Peqlab 
Octet RED System Forté Bio 
PCR Cycler Eppendorf 
PharosFX imager system BioRad 
pH-Electrode Schott 
pH-Meter Schott 
Pipettes Rainin 
Pippetboy easypet Eppendorf 
Power supply Biorad 
Real time PCR cycler (MX3005P) Stratagene 
Rotors 
JLA 25.50 
JA 8.1000 
 
Beckmann Coulter 
Spectrophotometer Agilent 
Streptavidin tips Forté Bio 
Thermoblock Rotilabo-Block Heater 250 Roth 
Thermomixer Eppendorf 
  
Expendable Materials 
 
24-well plate Crystalgen 
96-well plate Greiner 
Concentrator MWCO 30,000 
Vivaspin15 
Vivaspin 20 
 
Sartorius Stedim Biotech 
Cover slides Jenabioscience 
Filter 0,22 µm Roth 
Greinertube 15 ml, 50 ml Greiner 
Pipette tips 10 µl, 200 µl, 1000 µl, 5000 µl Rainin 
Reactiontube 1.5 ml Eppendorf 
UVette Eppendorf 
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2.3 Bacterial cell culture 
2.3.1 Bacterial strains 
Table 2.2: Bacteria strains used in this work 
Name Genotype Source 
BL21-CodonPlus(DE3)-RIL E.coli B F-ompT hsdS(rB-mB-) dcm+ Tetrgal 
I (DE3) endA Hte [argU ileY leuW Camr] 
Stratagene 
DH5α F- φ80lacZ∆M15 ∆(lacZYAargF) U169 
deoR recA1 endA1hsdR17(rk-, mk+) 
phoAsupE44thi-1 gyrA96 relA1 λ- 
Invitrogen 
 
 
 
 
2.3.2 Expression plasmids 
Table 2.3: Expression plasmids used in this work 
Name Vector Tag Source 
taXPD (T3) pET16b N-terminal His J. Truglio 
taXPD (T4) pET16b N-terminal His J. Truglio 
taXPD pBadM11 N-terminal His F. Rohleder 
taXPD mutants pET16b N-terminal His  
faXPD pET28a N-terminal His N. Mathieu 
 
2.3.3 Media for bacterial cell culture 
Table 2.4:  Media for bacterial cell culture used in this work 
Name Composition 
LB-Media 10 g/l Tryptone 
  5 g/l yeast extract 
10 g/l NaCl 
 
LB-Agar 10 g/l Tryptone 
  5 g/l yeast extract 
10 g/l NaCl 
15 g/l Agar 
  
 
  
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2.3.4 Media additives 
Table 2.5: Media additives used in this work 
Substance Stocksolution Final concentration 
Ampicillin 100 mg/ml in ddH2O 100 µg/ml 
Chloramphenicol 34 mg/ml in 70 % Ethanol 34 µg/ml 
IPTG 1 M 0.1 mM  
Arabinose 20 % 0.02 % 
 
2.4 Enzymes 
Table 2.6: Enzymes used in this work 
Enzyme Source 
DpnI New England Biolabs 
Phusion DNA Polymerase Finnzymes 
T4 polynucleotide kinase Invitrogen 
Desoxyribonuclease I Invitrogen 
Proteinase K Roth 
 
2.5 Nucleotides and oligonucleotides 
Table 2.7 Nucleotides and oligonucleotides used in this work 
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Annealing of F1522/NDB40, F2140/NDB24, MJD1/NDB and XPD DNA1/XPD 
DNA2 results in 5’-overhang substrates and annealing of NDT/NDB8, 
NDT/NDB16, CPD/NDB8, CPD/NDB16, F2650/NDB8 and F2650/NDB16 in bubble 
substrates, with 8 and 16 bases being mismatched, respectively. Annealing of 
XPD_top/XPD_bottomand K10T/U_K10T results in open fork substrates. 
For sequences of mutagenesis primers see apendix. 
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2.6 Buffer and solutions 
All buffers were adjusted to the respective pH value by adding either 32 % (w/v) 
NaOH or 37 % (v/v) HCl. 
Cell lysis and protein purification 
Lysis buffer Elution buffer SEC buffer 
20 mM Tris pH 8 
500 mM NaCl 
5 mM Imidazole 
20 mM Tris pH 8 
500 mM NaCl 
500 mM Imidazole 
20 mM Tris pH 8 
300 mM NaCl 
10 mM MgCl2 
 
Reaction buffers 
Octet Reaction buffer ATPase reaction buffer Helicase reaction buffer 
20 mM Tris pH 8 
150 mM NaCl 
10 mM MgCl2 
1 mg/ml BSA 
60 mM HEPES pH 7.2 
10 mM KCl 
20 mM MgCl2 
0.5 mM DTT 
0.5 mM CaCl2 
 
20 mM Tris pH 8.5 
10 mM NaCl 
5 mM MgCl2 
1 mM EDTA 
2 mM DTT 
 
 
Additional buffers 
Staining solution 
50 % Methanol 
10 % Acetic acid 
0.1 % Coomassie brilliant  
blue 
Destaining solution 
10 % Methanol 
5 % Acetic acid  
Running buffer (1x) 
192 mM Glycine 
0.1 % SDS 
25 mM Tris 
 
Loading buffer 
50 mM Tris pH 6.8 
100 mM DTT 
2 % SDS 
0.1 % Bromphenol blue 
 
15 % Resolving Gel 
15% AA/ BAA 
375 mM Tris pH 8.8 
0.1 % SDS 
0.25 % APS 
0.05 % TEMED  
 
5 % Stacking Gel 
15% AA/ BAA 
125 mM Tris pH 6.8 
0.1 % SDS 
0.25 % APS 
0.15 % TEMED 
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1x TE buffer 
10mM Tris pH 8 
1mM EDTA 
8% native Gel 
8% AA/ BAA 
0.5x Trisglycine pH 8 
0.2 % APS 
0.1 % TEMED 
1x Trisglycine buffer 
25 mM Tris base 
192 mM Glycine 
 
 
2.7 Oxidants and reducing agents 
Table 2.8: Oxidants and reducing agents used in this work 
Chemical Source Redox potential 
Sodium dithionite Roth Eox = -460 mV 
Ir(Cl)62- Lisa Engstrom Eox = 892 mV 
K3Fe(CN)6 Roth Eox = 424 mV 
Potassiumsuperoxide Acros Organics  
Peroxynitrite Lisa Engstrom  
NO Lisa Engstrom  
H2O2 Roth Eox = 692 mV 
Co(phen)33+ Lisa Engstrom Eox = 370 mV 
Co(5-Cl-phen)33+ Lisa Engstrom Eox = 430 mV 
 
2.8 Kits 
NucleoBond Plasmid Kit Macherey & Nagel 
 
2.9 Crystallization screens 
Table 2.9: Crystallizationscreens used in this work 
Name Source 
Additive Screen Hampton Research 
Crystal Screen I, II Hampton Research 
Index Screen HT Hampton Research 
JCSG Screen Qiagen 
Nextal PEG Suite Qiagen 
Nucleix Suite Qiagen 
Optimix 1 - 5 Topaz 
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Protein Complex Screen Qiagen 
Wizard Screen 1 Emerald BioSystems 
Wizard Screen 2 Emerald BioSystems 
 
2.10 Computersoftware 
Table 2.10: Software used in this work 
Software Author/Reference 
Arp/Warp (Morris et al. 2003) 
CCP4 program suite (1994) 
Coot (Emsley and Cowtan 2004) 
ESyPred3D web server (Lambert et al. 2002) 
ExPASY Proteomics Server http://www.expasy.ch/ 
Mosflm (Battye et al. 2011) 
O (Jones et al. 1991) 
Octet RED Software Analysis 6.3 Forté Bio  
OriginPro 8.5 Origin Lab Corporation 
PDB www.pdb.org 
Phaser (McCoy et al. 2007) 
Phenix.refine (Adams et al. 2010) 
Pirate (1994) 
Pymol DeLano 2002 
Quantity One (Molecular Imager) Biorad 
Refmac5 (Murshudov et al. 1997)  
Scala (Evans 2006) 
Sharp (De La Fortelle and Bricogne 1997) 
ShelxD (Schneider and Sheldrick 2002) 
Solomon (Abrahams and Leslie 1996) 
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3 Methods 
3.1 Molecular biology techniques 
3.1.1 Mutagenesis 
XPD mutants were generated by site-directed mutagenesis. Two complementary 
primers with a length between 20 and 40 bases were designed both carrying the 
mutated sequence. A two-step protocol was carried out with eight PCR cycles 
containing just one primer each to avoid the formation of primer dimers (Wang and 
Malcolm 1999). The single reactions including forward and reverse primers were 
combined and 25 additional PCR cycles were performed. 
 
The reactions were composed of the following reagents: 
Table 3.1: Contents of PCR reaction 
 Stock concentration Final concentration Amounts for 25 µl 
reaction 
Reaction buffer 5 x 1 x 5 µl 
Template 100 ng/ µl 100 ng 1 µl 
Primer 10 µM 400 nM 1 µl 
dNTPs 10 mM 400 µM 1 µl 
Phusion Polymerase 
  0.5 µl 
ddH2O   16.5 µl 
 
The following PCR program was used: 
Table 3.2: PCR program used in this work. 
Step Temperature Time Cycles 
Initial Denaturation 98 °C 30 sec  
Denaturation 98 °C 10 sec        8 cycles for each 
Annealing 65 °C 30 sec        primer reaction, 25 
Extension 72 °C 90 sec        cycles for combined 
Final Extension 72 °C 5 min        reaction 
cooling 4 °C forever  
 
Afterwards, 10 U of DpnI were added to each reaction tube and incubated for 1h at 
37ºC. 10 µl of the digested DNA were transformed into DH5αcompetent cells, 
plated on an ampicillin Luria Broth (LB) agar plate and incubated overnight at 
37ºC. DNA was extracted from single colonies and checked for the introduced 

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mutation using DNA sequence analysis at Seqlab – Sequence Laboratories 
Göttingen GmbH (Göttingen). 
 
3.1.2 Plasmid isolation 
A single colony grown on a LB-agar plate was picked and transferred to a 5 ml 
liquid culture containing LB and the appropriate antibiotics. After the cells were 
grown at 37°C, 200 rpm over night the suspension wa s centrifuged at 4,000 rpm 
for 10 min (Centrifuge 5810R, Eppendorf) to pellet the cells. The cells were then 
lysed and DNA was extracted using the NucleoBond Plasmid Kit (Macherey-
Nagel) according to the manual. 
 
3.1.3 Labeling and duplexing of single-stranded DNA 
For 32P-labeling, ssDNA was 5’-end labeled for 10 min at 37°C in a 25 µl reaction 
solution containing 200 nM ssDNA, 1 µCi/µl [γ32P]-ATP (Hartmann Analytic), 1x 
forward buffer and 10 U T4 Polynucleotide Kinase (NEB). SsDNA was purified 
using MicroSpinTM G25 columns (GE Healthcare) to remove unincorporated [γ32P]-
ATP and subsequently annealed with the counter oligonucleotide in the presence 
of 0.1x TE buffer containing 100 mM KCl by heating the sample to 80°C and 
subsequent cooling slowly to RT. Fluorescently labeled ssDNA was purchased 
from Biomers. 
 
3.1.4 Transformation 
1 µl of plasmid DNA (100 ng/µl) was added to an aliquot (100 µl) of chemo-
competent Escherichia coli (E.coli) BL21-CodonPlus (DE3)-RIL cells (Stratagene). 
The cells wereincubated on ice for 30 minutes and after this heat-shocked at 42ºC 
for 90 sec. The cells were then put on ice for 2 min. After adding1 mLLuria Broth 
(LB) medium, the cells were incubated at 37ºC for 1h (600 rpm; Eppendorf 
Thermomixer). Afterwards the cellswere plated on a LB-agar plate with the 
appropriate antibiotics and incubated overnight at 37ºC. 
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The antibiotics ampicillin (Amp) and chloramphenicol (Cam) were used for LB-agar 
plates and liquid cultures in the concentrations 100 µg/mL and 34 µg/mL, 
respectively  
 
3.2. Protein expression 
The 200 mLLB-medium with the appropriate antibiotics Amp/Cam was inoculated 
with one colony of a fresh transformation and was incubated overnight (37°C, 200 
rpm). For large scale expression 2 L Luria Broth (LB) Media (Amp/Cam) were 
inoculated with 20 mL of an overnight-culture. The culture was incubated (37°C, 
200 rpm) to an OD600 of 0.5 to 0.6 and at this point protein expression was 
induced. For Induction 0.1 mM isopropyl-β-thiogalactoside (IPTG) (pet16b, pet28a) 
or 0.02% Arabinose (pBadM11) was added. Upon induction the temperature was 
decreased to 14°C and after 18 to 20h the cells wer e harvested by Centrifugation 
(Rotor JLA 8.1000, 4°C, 5000g, 20 min; Beckmann Cou lter Avanti Centrifuge J-26 
XP) and stored at -80°C. 
 
3.3 Protein purification 
3.3.1 Cell lysis 
The cells were resuspended in Lysisbuffer (20 mM TrisHCl pH 8, 500 mM NaCl, 5 
mM imidazole) and 5 µL of DNase I was added. The cells were lysed by passing 
the cell suspension twice through the cell disruptor at a pressure setting of 1.8 
kbar. Afterwards the celllysate was centrifuged to separate soluble proteins from 
insoluble proteins and celldebris (Rotor JA 25.50, 4°C, 30000g, 1 h; Beckmann 
Coulter Avanti Centrifuge J-26 XP). The soluble expressed protein in the 
supernatant was used for protein purification. 
 
Proteinpurification was performed in two steps. First affinity chromatography was 
applied followed bysize exclusion chromatography. 
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3.3.2 Affinity chromatography – Ni 2+ column 
Affinity chromatography is based on properties of biological macromolecules to 
specifically and reversible bind other substances (ligands). Polyhistidine-tags exert 
a strong affinity to Ni2+-ions. The matrix of the Ni2+-column consists of Ni-NTA 
agarose (Invitrogen) that is charged with Ni2+-Ions. Proteins containing a His6-or 
His10-tag thus can be bound to the column and eluted by the addition of the 
competitor imidazole which is chemically and structurally similar to histidine 
residues. 
XPD contains as affinity-tag polyhistidine residues that bind nickel-ions with high 
affinity. The six (pET28a) or ten (pET16b) histidine residues are located at the N-
terminus of the protein. 
First the column was equilibrated with 5 column volumes (CV = 5 ml) of Lysisbuffer 
(20 mM TrisHCl pH 8, 500 mM NaCl, 5 mM imidazole). Afterwards the 
proteinsolution was applied to the column. To eliminate unbound protein the 
column was washed with 10 CV of Lysisbuffer. The bound protein was eluted with 
Elutionbuffer (20 mM TrisHCl pH 8, 500 mM NaCl, 500 mM imidazole). The 
different fractions were analyzed on a 15% SDS-Gel(Laemmli 1970). The 
elutionfractions containing the protein were combined and concentrated to 5 mL. 
 
3.3.3 Size exclusion chromatography 
Size exclusion chromatography (SEC) was performed on an ÄKTA-Purifier-
Chromatography-System (GE Healthcare) equipped with a sample loading pump 
P960, a Monitor pH/C-900 for measurement of pH, conductivity, and temperature 
and a UV900 Monitor for UV-Vis detection of up to three wavelengths 
simultaneously. The fraction collector Frac-950 was connected to the Äkta system 
and was used for automated collection of the elution fractions. 
Via SEC proteins are separated by size and form. The resin of the Superdex 200 
XK 26/60 consists of dextran, which is covalently attached to agarose. The 
columnvolume of Superdex 200 XK 26/60 is 330 ml and proteins with a size 
between 10 kDa and 600 kDa can be separated. Large proteinmolecules cannot, 
in contrast to small proteins, enter the particles and therefore elute earlier. 
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The Superdex 200 XK 26/60 column was equilibrated with SEC buffer (20 mM 
TrisHCl pH 8, 300 mM NaCl, 10 mM MgCl2). The proteinsolution was applied with 
a sample loop to the column and the SEC was performed with a flow of 1 ml/min 
for 1.2 CV. UV-detectors for various wavelengths were applied. Nucleic acids were 
detected at 260 nm, protein at 280 nm and the iron sulfur cluster of XPD at 410 
nm. The 280 nm peak fractions were checked on a 15% SDS-Gel(Laemmli 1970). 
 
3.4 Protein characterization  
3.4.1 SDS-PAGE analysis 
Via a sodium dodecyl sulfate (SDS) polyacrylamid gel electrophoresis (SDS 
PAGE) proteins are separated according totheir molecular weight under 
denaturing conditions. SDS is a strong anionic detergent thatbinds to the main 
chain of the proteins so that the charge of the SDS-protein complexes isabout 
proportional to the molecular weight of the protein. Additionally, a reducing agent 
is used to disruptpossible disulfide bonds. Proteins are thereby separated in an 
electrical field according to their size,independently of their natural charge or 
conformation. 
After each purification step, an SDS PAGE (Laemmli 1970)was run, to identify the 
fractionscontaining the protein and to analyze the grade of purity. For the 
estimation of the molecularweight of the different protein bands, the PageRuler 
prestained protein ladder (Fermentas) thatshows bands between 10 and 170 kDa 
was loaded in one of the lanes of the gel. Beforeloading on the gel, 10 µL of the 
protein sample was mixed with 3 µL 5x protein samplebuffer, heated for 5 min at 
95° C and was loaded onto the gel. The run wasperfo rmed for 45 min at 200 V. 
The gel was stained for 20 min in coomassie staining solution (see 2.6) and the 
unbound stain was removed afterwards with destaining solution (see 2.6) 
(Laemmli 1970). 
 
3.4.2 Determination of the protein concentration 
The concentration of the purified proteins was determined with a nanodrop UV/Vis 
spectrophotometer (Peqlab) using the spectrum mode from 175 nm to 875 nm. Via 
the Lambert-Beer law one can calculate the protein concentration c from the 
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extinction coefficient ε, the absorbance at 280 nm A and the thickness of the 
cuvette d (Pfeiffer and Liebhafsky 1951). 
     
The extinction coefficient can be defined with the help of the number of the 
tryptophan-, tyrosine- and cysteine-Residues applying the following formula: 
ε280 = (nTrp·5690+nTyr·1280+nCys·120) 
The Thermoplasma acidophilum XPD (taXPD) monomer containes two 
tryptophanes, 36 tyrosines and eight cysteines, the calculated extinction coefficient 
ε280 is 65,140 M-1cm-1.The molecular weight of taXPD is 72 kDa. 
The Ferroplasma acidarmanus (faXPD) monomer containessixtryptophanes, 39 
tyrosines and sevencysteines, the calculated extinctioncoefficient ε280 is 98,415 M-
1cm-1. The molecular weight of faXPD is 72 kDa. 
 
3.4.3 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is a form of light absorption spectroscopy 
that measures the difference in absorbance of right- and left-circularly polarized 
light by chiral molecules. CD spectroscopy can be used to analyze the secondary 
structure of polypeptides and proteins (Kelly et al. 2005). Here, CD measurements 
were performed at 20°C using a Jasco J-810 spectrop olarimeter. Measurements 
on taXPD and faXPD were carried out in 200 µl volume in 50 mM Na-phosphate 
pH 7.8 at a protein concentration of 0.1 mg/ml. Spectra were registered from 260 
to 190nm and accumulated eight times with a scan speed of 20 nm/min,  
 
3.4.4 ThermoFluor analysis 
A ThermoFluor analysis is based on the use of fluorescence measured upon 
thermal unfolding of the analyzed protein. An environmentally sensitive fluorescent 
dye that interacts specifically with denatured protein is used as an indicator. A 
soluble protein contains a hydrophilic surface which makes it possible to interact 
with the solvent, however the core of the protein is usually hydrophobic. The dye is 
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quenched in aqueous environments only upon unfolding of the protein the dye can 
bind to the hydrophobic interior of the protein resulting in a large increase in 
quantum yield (Matulis et al. 2005). 
The midpoint of the protein unfolding transition is defined as the melting 
temperature Tm at which folded and unfolded states of the protein are equally 
populated. 
Here the ThermoFluor analysis was applied to determine whether the wild-type 
and XPD variants are folded in a similar way. For the thermal unfolding assays 5 
µL of the protein sample in its respective buffer and 5 µL of the SYPRO® Orange 
dye (Sigma-Aldrich) in DMSO were added to 15 µL buffer in a concentration of 100 
mM in a 96 PP-PCR-plate (Greiner Bio-One International AG). The experiment 
was performed in a Real-Time PCR system (Stratagene Mx3005PTM). The 
program comprises 70 steps with the first step conducted at 25°C. With each 
subsequent step, the temperature is increased by 1°C and thus the last step’s 
temperature is 95°C. The results analysis was carri ed out with an excel sheet 
provided by the Structural Genomics Consortium (SGC) in Oxford. 
 
3.4.5 In vitro ATPase assay 
XPD ATPase activity was measured with a in vitro ATPase assay, in which ATP 
consumption is coupled to the oxidation of NADH via pyruvate kinase and lactate 
dehydrogenase activity. Activities were measured at 37°C in 50 µL solution, 
containing 1.5 U pyruvate kinase, 1.9 U lactate dehydrogenase, 2 mM 
phosphoenolpyruvate and 0.15 mM NADH, 10 mM KCl, 20 mM MgCl2, 0.5 mM 
DTT, 0.5 mM CaCl2 and 60 mM HEPES (pH 7.2). SsDNA was added at a final 
concentration of 0.5 µM. Under saturating concentrations of ATP (2 mM) 
measurements were carried out using XPD wild-type and variants at a 
concentration range of 200-2000 nM. For catalytic measurements, the mix of all 
reagents, with the exception of ATP, were pre-incubated at 37°C until a stable 
base line was achieved. Enzyme catalysis was initiated by the addition of ATP. 
The activity profiles were measured at 340 nm, using an Agilent 8453 diode array 
spectrophotometer. The initial velocities were recorded and using the molar 
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extinction coefficient of NADPH ATP consumption was determined. The 
measurements were carried out in triplicates using different protein batches. 
 
3.4.6 Biolayer Interferometry 
Real time binding assays between ssDNA and purified taXPD wild-type and 
variants were performed using biolayer interferometry on an Octet RED system 
(Fortebio, Menlo Park, CA). This system monitors interference of light reflected 
from the surface of a fiber optic sensor to measure the thickness of molecules 
bound to the sensor surface. 3’-biotinolyted DNA was obtained from Biomers and 
coupled to kinetics grade streptavidin biosensors at a concentration of 100 nM. 
Sensors coated with ssDNA were allowed to bind taXPD in a reaction buffer 
containing 20 mM Tris (pH8), 150 mM NaCl, 10 mM MgCl2, 1 mM DTT and 1 
mg/ml BSA at different taXPD concentrations ranging from 0.5 to 5 µM. The 
measurements were carried out in triplicates using different protein batches. 
Binding kinetics were calculated using the Octet Data Analysis Software 6.3, with 
a 1:1 binding model to calculate the association rate constants. Binding affinities 
were calculated as the ratio of dissociation and association rate constants. 
 
3.4.7 Gel-based helicase assay 
To investigate DNA unwinding activity, helicase assays were performed by 
incubation of 500 nM protein, 50 nM DNA substrate and 1 µM competitor 
oligonucleotide in helicase reaction buffer for 5 min at RT (see 2.6).The reaction 
was started by addition of 5 mM ATP. Stop buffer containing 10 mM TrisHCl, pH 
8.0, 5 mM EDTA, 0.5% SDS, 1mg/ml Proteinase K and 5 µM competitor DNA was 
added and incubated for 15 min at RT to digest the helicase and to prevent the 
unwound DNA from re-annealing. Then 6x sample buffer (Invitrogen) was added 
and samples were separated at 100 V on a 8 % native polyacrylamide gel. Gels 
containing 32P-labeled DNA were exposed to a phosphoimager screen over night, 
fluorescently labeled DNA comprising gels were directly visualized by the 
PharosFXTM imager system (BioRad). 
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3.4.8. Fluorescence based helicase assay
Helicase activity was analyzed utilizing a fluorescence based helicase assay 
(Martinez-Senac and Webb 2005
3’-end of the translocated strand oligonucleotide and
5’-end of the opposite strand was used. This results in a quenching of the cy3 
fluorescence that is removed upon unwinding of the substrate. Assays were 
carried out in 20 mM Tris (pH 8.5), 10 
mM DTT. 800 nM of protein were mixed with 40 nM open fork substrate and 800 
nM capture oligonucleotide. The reaction was subsequently started with the 
addition of 500 µMATP. Kinetics were recorded with a Flouromax4 fluo
spectrometer (Horiba Jobin Yvon) and monitored until the reaction was completed 
Fluorescence was detected at an excitation wavelength of 550 nm (slidwidth 2nm) 
and an emission wavelength of 570 nm (slidwidth 2 nm). Initial velocities were 
fitted with Origin8 and represent the averages of at least two different reactions 
and two independent protein batches. 
 
3.4.9 Electron paramagnetic r
EPR is a spectroscopic technique which detects transitions of unpaired electrons 
in an applied magnetic field. Like a proton, the electron has a spin, which gives it a 
magnetic property known as a magnetic moment. The magnetic moment makes 
the electron behave like a bar magnet. 
Figure 3.1: Variation of the spin state energies as a function of the ap
fieldtaken from (http://www.bruker
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When an external magnetic field is supplied the paramagnetic electrons can either 
orient in a direction parallel or antiparallel to the direction of the magnetic field. 
This creates two distinct energy levels for the unpaired electrons and allows 
measuring them as they are driven between the two levels. 
From quantum mechanics the most basic equation of EPR is obtained, where ∆E 
is the energy difference between the two levels of the electrons, h is the Planck’s 
constant, v is the frequency of the radiation, g is the g-factor, µB is the moment of 
the electron and B0 is the magnetic field. 
∆E = h·ν = g·µB·B0 
To measure EPR the sample is transfered into an EPR spectrometer. The 
spectrometer consists of a magnet, a cavity, a bridge, a signal channel, a field 
controller and a computer. The sample is placed in the microwave cavity, which is 
a metal box that helps to amplify weak signals from the sample. The microwave 
bridge contains the microwave source and the detector. The signal channel 
houses the required electronics for the phase sensitive detection, a technique 
used to enhance the sensitivity of the spectrometer. The magnetic field controller 
makes it possible to sweep the magnetic field in a controlled and precise manner 
for the EPR experiment. 
 
Figure 3.2: Block diagram of an EPR Spectrometertaken from (http://www.bruker-biospin.com)K
1. 
To acquire a spectrum the frequency of the electromagnetic radiation is changed 
and the amount of radiation which passes through the sample is measured with a 
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detector to observe the spectroscopic absorptions. Because spectra can be 
acquired at several different frequencies, the g-factor which is independent of the 
microwave frequency is a unique character for the identification of a compound. 
High values of g occur at low magnetic fields and vice versa. 
g = h·v / (µB·B0) 
In these experiments taXPD with or without DNA was incubated for 10 min at 37°C 
in the presence of different reactive chemicals, transferred to an EPR tube, and 
carefully and slowly frozen in liquid nitrogen to allow the air to exhaust of the 
sample.  
 
3.5 Crystallization 
To determine the structure of a protein by x-ray diffraction, a well-ordered single 
protein crystal is required which is characterized by a consistent homogeneous 
crystal lattice. Therefore highly pure protein is needed (95% purity on a SDS-gel). 
Crystallization requires that molecules exchange from a supersaturation state into 
a solid state. Several techniques have been developed to achieve the 
supersaturation state: microbatch crystallization, dialysis and vapor diffusion for 
example. In this work only the vapor diffusion method was used.  
 
Figure 3.3: A schematic drawing of a protein crystallization phase diagram. This is based on 
two of the most commonly varied parameters, protein and precipitant concentrations. The diagram 
displays how supersaturation is achieved to trigger crystallization in vapor diffusion (B) and other 
crystallization methods. (Reprinted with permission by IUCr, Acta Crystallographica Section D: 
Biological Crystallography(Chayen 1998), ©1998) 
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For vapor diffusion (Figure 3.3, line B, (Chayen 1998)) the protein solution is 
combined with crystallization solution containing an adequate precipitant. The 
precipitant displaces at a certain concentration the protein molecules from the 
solution. In a sealed reservoir, the drop solution is equilibrated against a much 
larger reservoir of the crystallization solution. This technique can be performed in 
two different ways eitherby placing the drop on a shelf that is surrounded by the 
reservoir solution (sitting drop) or by hanging the drop from a cover slide towards 
the reservoir solution (hanging drop). In both cases, diffusion of H2O from the drop 
to the reservoir slowly increases the precipitant and the protein concentration in 
the drop, the nucleation barrier is accomplished and small crystal nuclei form. 
Upon formation of nuclei, the protein concentration in the drop is decreased and 
the condition in the drop is pushed towards the metastable zone where growth of 
crystals at the nucleation sites occurs. The sitting drop method was used for initial 
screening for suitable conditions with the HoneyBee 963 crystallization robot 
(Zinser Analytik). The drop contained 0.3 µL protein solution and 0.3 µL 
crystallization solution and was equilibrated against 40 µL reservoir solution in a 
96-well crystallization plate (Greiner Bio-One International AG). The hanging drop 
method was used for the follow-up screens where the drop (1 µL protein solution 
pipetted on 1 µL crystallization solution) was equilibrated against 1 mL reservoir 
solution. 
 
3.6 X-ray crystallography 
3.6.1 Data collection 
An x-ray beam that encounters a crystal lattice of atoms or molecules induces 
oscillation of the electrons in the lattice at the x-ray frequency. Upon returning to 
the unexcited state, the electrons emit radiation at the original energy and 
wavelength in a random direction. The scattered waves can be described as 
reflections at the lattice planes of the crystal. In most directions the scattered 
waves add up to zero (destructive interference). When the x-ray beam hits the 
lattice plane under the glancing angle θ and Bragg’s law is satisfied, constructive 
interference takes place and reflections appear at the detector. The intensity and 
the position of the reflections are measured in the diffraction experiment. From the 
position of the reflections the Miller indices h, k, l can be determined. 
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Bragg’s law 
n·λ = 2·d·sin θ 
The electron density distribution ρ at every point in the unit cell (x,y,z) is calculated 
by the inverse Fourier transformation over all structure factors F(hkl). 
inverse Fourier transformation 
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The measured intensity (I(hkl)) of a reflection is proportional to the square of the 
structure factor amplitude |F(hkl)|. To calculate the structure factor F(hkl) from the 
intensity, the phase φ of the wave is needed. The phase information cannot be 
determined during data collection and is lost. This fact is termed the phase 
problem of crystallography. Several methods exist to solve the phase problem. In 
this work multiwavelength anomalous dispersion and molecular replacement were 
used.  
Calculation of structure factors 
I(hkl) = |F(hkl)|2 
F(hkl)=|F(hkl)ei·φ(hkl)| 
I(hkl): Intensity of the scattered waves, F(hkl): structure factor 
For data collection, a single crystal was fished with a nylon loop (Hampton 
Research) out of the mother liquor, transferred into a cryo-protectant and frozen in 
liquid nitrogen. The cryo-protectant is used to prevent formation of ice crystals 
when the crystal is frozen and typically contains solvents like glycerol or 
polyethylene glycol together with the mother liquor of the protein crystal. As the 
XPD crystals grew in MPD and PEG 400 conditions, MPD and glycerol were 
chosen as cryo-protectant, respectively. The crystals were transferred from their 
mother liquor to a crystallization solution containing 5% glycerol. The 
concentration of the cryo-protectant was increased 5% stepwise up to a final 
concentration of 30 % glycerol by just dipping the crystal shortly into the particular 
solution. Crystals from MPD conditions were directly transferred to a cryo-solution 
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containing 30 % MPD. After one minute in the solution, the crystals were fished 
out with a cryo-loop and flash frozen in liquid nitrogen. 
For data collection, a cryo-loop containing one single crystal was mounted in the 
beam path and simultaneously cooled by a cryogenic gas stream of nitrogen at 
100 K.Diffraction data were collected at a synchrotron. In a synchrotron electrons 
and positrons are accelerated and then injected into a storage ring where they 
circulate near the speed of light, guided by bending magnets. Synchrotron 
radiation is emitted when the charged particles go through the bending magnets, 
or through wigglers or undulators, which are additional magnetic devices inserted 
into the straight sections of the ring. The radiation is captured by beam lines and 
guided to experimental stations that contain instrumentation for diffraction 
experiments. 
 
3.6.2 Multiwavelength anomalous dispersion (MAD) 
MAD utilizes anomalous scattering elements like endogenous iron and selenium 
that can be incorporated into proteins. When the energy of an incident X-Ray 
beam is varied across the absorption edge of an anomalous scatterer, there are 
substantial changes in the real and imaginary components (f’ and f”) of the X-ray 
scattering. Thus, qualitatively, multiwavelength anomalous dispersion experiments 
can be thought of as in situ isomorphous replacements generated by the variation 
in scattering strength that accompanies the change of the wavelength. The MAD 
technique requires the special properties of synchrotron radiation since data have 
to be collected at different wavelegths, but it has the advantages that isomorphism 
is perfect and all data can be measured from a single crystal. 
In the case of small molecules, a direct solution of the phase problem is possible 
from statistical relations among the intensities. For these direct methods, a single 
native X-ray data set is sufficient, without the use of fragments of known structures 
or the need to prepare heavy-atom or selenomethionine derivatives, provided that 
the data are available at atomic resolution. Nowadays, direct methods are used 
routinely to locate the positions of heavy-atoms in isomorphous replacement or 
anomalous scatterers in MAD phasing of large proteins at moderate solutions. 
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In the present work, structure solution was achieved utilizing the anomalous signal 
of the endogenous Fe belonging to the 4Fe4S cluster at the Fe edge. 
 
3.6.3 Molecular replacement 
Molecular replacement is a method to solve the phase problem by using an 
already available structure with high homology to the unknown structure. This 
structure,here 2VSF was used as a search model, should have at least 25- 30 % 
sequence identity and has to be positioned correctly in the unit cell of the unknown 
structure. This is done by calculating a Patterson function of the measured data of 
the unknown structure and of the structure of the search model. The advantage of 
the Patterson function is that no phase information is needed for calculation. In the 
rotation function the correct orientation of the search model is calculated by 
rotation of the self-Patterson vectors of the search model over the Patterson map 
of the unknown structure. The correct orientation of the search model is indicated 
by a maximum correlation of the intra-atomic vectors (self-vectors) of the two 
structures. The translation function is used to find the correct position of the 
oriented search model in the unit cell. Analogous to the rotation function, the 
translation function consists of superimposing the cross-Patterson vectors from the 
search model on the Patterson map of the unknown structure until a maximum of 
the inter-atomic vectors (cross-vectors) indicates the exact position of the search 
model. Finally, an initial electron density map can be calculated using the structure 
factor amplitudes of the measured data and the phases of the correctly positioned 
search model. A six-dimensional search is computationally very intensive (three 
rotation variables and three translation variables), the six variables are therefore 
often determined in two steps with the rotation search first following the translation 
search.  
With the known molecular weight of the protein (Mr), the volume of the unit cell 
(VEZ) and the number of symmetry operators in the space group (z), the number of 
molecules (n) in the asymmetric unit can be estimated with the method of 
Matthews. 
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Calculation of Matthews coefficient 
VM = VEZ / Mr·z·n 
 
VM is the packing parameter that describes the crystal volume per protein mass. 
With VM the solvent content of the protein crystal can be calculated which is 
typically between 30 % and 70%. 
 
3.6.4 Model building and refinement 
After structure solution, usually an incomplete model is obtained that contains 
many errors. In order to produce an accurate model, the structure is manually 
modified in real space fitting the amino acids to the electron density and adding 
molecules like water, cofactors and DNA. For model building, the programs 
Coot(Emsley and Cowtan 2004) and O (Jones et al. 1991) were used which are 
molecular graphics applications with the primary focus on crystallographic 
macromolecular model building and manipulation. During crystallographic 
refinement, the model parameters like coordinates and B-factors are processed in 
the reciprocal space to improve the fit of observed and calculated structure-factor 
amplitudes. In order that the system is not under-determined, it is important that 
the number of parameters that define the structure do not exceed the number of 
observed reflections. This can especially be an issue when working with huge 
structures or at low resolution. Fortunately, it is possible to improve the data to 
parameter ratio by adding additional information to the measured intensities and 
the derived structure factor amplitudes. Restraints are conditions that apply within 
a certain standard deviation for the model. Information about the molecular 
geometry (bond lengths and bond angles), planarity of peptide bonds and phenyl 
groups and atomic distances can be restrained. If more than one molecule is 
present in the asymmetric unit, they can be related by non-crystallographic 
symmetry (NCS) and the geometry can be restrained to be similar (NCS-
restraints). Restraints increase the amount of data available for refinement. 
Constraints are conditions that apply exactly for the structure, reducing the number 
of independent parameters to be refined. The occupancy of one atom is usually 
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constrained to be exactly 1.0. Displacement parameters can be constrained or the 
bond lengths and bond angles of hydrogen atoms.  
Upon refinement, the phases become more accurate and an improved electron 
density can be calculated. The program Refmac5 (Murshudov et al. 1997) was 
used for maximum likelihood refinement. Alternating rounds of model building and 
automated refinement were carried out to successively improve the atomic model. 
The success of refinement is evaluated by the R-factor that measures the 
agreement between the crystallographic model and the measured data. A 
decreasing R-factor indicates that the model has improved. 
Calculation of the R-factor 
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As the R-factor is related to data that is used during refinement, the obtained value 
might be biased towards the model. To prevent over-fitting of the data a more 
objective quality indicator, the free R-factor (Rfree) was introduced (Brunger 1997), 
(Kleywegt and Jones 1997). For calculation of the Rfree, a fraction of 5-10% of the 
data are randomly chosen and not used for the refinement process. After each 
refinement cycle, the Rfree is calculated from these data. If after refinement only the 
R-factors decrease and the Rfree stays the same or even increases, the data might 
have been over fitted and the structure has to be carefully reanalyzed. In general, 
the R-factor is an indicator of the precision of the model while the Rfree displays 
more the accuracy of the model. 
After interpretation of all features of the electron density map and when the R-
factors indicate an appropriate value and convergence, refinement can be 
considered as complete. To evaluate the quality of the final model parameters like 
appropriate geometry, deviations of the bond lengths and angles from ideal values 
and unusual rotamers of amino acids are inspected. However, these parameters 
are often heavily restrained during refinement or closely monitored during 
rebuilding and are therefore not independent criteria of the model-quality. An other 
criterion for model validation is the Ramachandran plot. In a Ramachandran plot, 
the dihedral angles φ and ψ of the amino acid residues in a protein structure are 
plotted against each other and show the possible conformations of φ and ψ angles 
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for a polypeptide. The diagram differentiates between the favored regions, the 
additional allowed regions and the disallowed regions while exceptions apply only 
for proline and glycine. If an amino acid is found to lie in the disallowed region 
(outlier) there are two possibilities: either the conformation indeed is wrong or the 
residue actually hadopts an unusual conformation. Amino acids with unusual 
conformations should have well defined electron density and are often found in 
important regions of the protein structure like the active site. 
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4 Results 
Archaeal organisms often exist in a more hostile environment as compared to 
eukaryotic organisms. This includes conditions like high temperature, high UV 
exposure, arid conditions or a very saline environment. Therefore archaeal 
proteins are often more robust as compared to their eukaryotic homologs. These 
characteristicsrender them very amenable for cloning and subsequent 
heterologous expression in E.coli. Because of the above mentioned advantages 
and the strong evolutionary relationship of archaea to eukaryotes we used the 
archaeonThermoplasma acidophilum as a model organism for proteins involved in 
eukaryotic NER in particular the XPD helicase. 
 
4.1 Protein expression and purification 
4.1.1 Proteinexpression and Purification of XPD WT and variants from 
Thermoplasma acidophilum 
The genes encoding XPDs from Thermoplasma acidophilum(taXPD) were cloned 
with variable N-termini (residues 1-622 and 23-622) into the pET16b vector using 
NdeI and XhoI restriction sites. This resulted in the constructs taXPDT3 and 
taXPDT4. PET16b::taXPD (either T3 or T4) was transformed into E.coli 
BL21(DE3) RIL cells as described in 3.1.4. One colony was used for the 
inoculation of the 200 mL overnight culture. 20 mL of the overnight culture were 
used to inoculate a 2 L cultures for large scale expression. To obtain sufficient 
amount of the protein large scale expressions of XPD between 16 L and 24 L cell 
culture were used. The bacteria were grown at 37°C to an OD600 of 0.5 to 0.6 and 
then induced with 0.1 mM IPTG. Upon induction the temperature was reduced to 
14°C and the cultures were incubated overnight at 2 00 rpm as described in 3.2. 
The cells were harvested and 1 L of cell culture yielded approximately 3 g wet cell 
paste. The cell pellets from 16 or 24 L cell culture were resuspended in 200 or 250 
mL lysisbuffer. The cells were lysed as described in 3.3.1 with a cell disruptor 
system and the soluble expressed protein was used for chromatographic 
purification.  
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Figure 4.1: Purification of taXPD.
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Elution fractions 3-6 were combined and concentrated with a Vivaspin 20 (MWCO 
30,000) to a final concentration of 50 µM. T
depicted in 3.4.2, 50 µL aliquots were flash frozen i
80°C. 
All taXPD variants were expressed and purified analog
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fractions. (C) 15% SDS-PAGE of the size exclusion chromatography run (A). M indicates the 
Marker and 1 to 3 the elution fractions of peak 1 and 4 to 9 the elution fractions of peak 2. 
The first purification step was an affinitychromatography via a Ni2+-column. The 
protein solution was applied to a Ni2+-NTA column, washed with 50 mL lysisbuffer 
and eluted with elution buffer containing 500 mM imidazole in four 5 mL fractions. 
The wash and elution fractions were analyzed on a 15% SDS-PAGE (Figure 4.2, 
B). The fractions containing the faXPD protein were combined and concentrated to 
5 mL. 
Afterwards size exclusion chromatography was applied as described in 3.3.3. The 
protein solution was filtered and loaded via a 5 mL loop on a Superdex 200 XK 
26/60 column. The protein was eluted with SEC buffer for 1 CV with a flow rate of 
1 mL/min. The A280 peak fractions were analyzed on a 15% SDS-PAGE. The 
chromatogram (Figure 4.2, A) shows two major peaks at A280. Peak 1 is most 
likely an faXPD containing aggregate since the corresponding fractions lanes 1,2 
and 3 in Figure 4.2, C contain protein at the size of about 72 kDa which 
corresponds to faXPD. The faXPD containing fractions 4-9 were pooled and 
concentrated with a Vivaspin 20 (MWCO 30,000) to a final concentration of 50 µM. 
The concentration was determined with a Nanodrop spectrophotometer as 
described in 3.4.2; 50 µL aliquots were flash frozen in liquid nitrogen and stored at 
-80°C. 
 
4.2 CD spectroscopy reveals that taXPD and faXPD are properly folded 
To check whether the two XPDs show an α/β-architecture indicating a proper 
folding of the proteins CD Spectroscopy was conducted as described in 3.4.3. The 
CD Spectra (Figure 4.3) reveal that taXPD and faXPD are folded properly in β-
Sheets and α-helices indicted by the characteristic minima at 208 nm and 222 nm. 
The two spectra are quite similar indicating that a similar amount of α-helices and 
β-sheets are present in the two proteins. Furthermore the spectra show that there 
are no disordered regions in the proteins indicated by the transition from negative 
to positive ellipticity values at a wavelength of approximately 200 nm. 

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Figure 4.3: CD Spectra of taXPD and faXPD. 
 
4.3 Crystallizationexperiments
4.3.1 Crystallization of taXPD
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(construct taXPDT4) was used 
condition 23 of crystal screen I sma
the crystallization condition and by streak
(Figure 4.4, B).  
TaXPD crystals were grown by vapor diffusion in hanging drops containing equal 
volumes of protein in 20 mM Tris/HCl (pH 8.0) and 500 mM NaCl at a 
concentration of 5 mg/mL
100 mM Hepes (pH 8), and 5%
solution. The optimized crystals were 
color (Figure 4.4, D). After 7 days the crystal growth was completed and the 
crystals had a final size of 100 µM x 5
appeared also in crystal scre
these crystals wasn’t successful. TaXPD was also co
of ATP and a non-hydrolysable analogue AMP
well diffracting crystals. 
-
TaXPD colored in black and faXPD colored in blue.
 
 
) screens were prepared as described in 3.5 a
at a concentration of 50 µM. After two days in 
ll crystals appeared (Figure 4.4, A
-seeding the crystals could be optimized
, and a reservoir solution consisting of 200 mM MgCl
–10% PEG 400 equilibrated against the reservoir 
of hexagonal shape and of yellow
0 µM x 50 µM. In the initial screens crystals 
en I in condition 49 (Figure 4.4, C), but optimization of 
-crystallized in the presence 
PNP. It was not possible to obtain 
 
 
nd taXPD 
). By varying 
 
2, 
-brownish 
"


Figure 4.4: Crystals of taXPD.
seeding optimized crystals. (C)
crystal. 
Since there was no structure
replacement a multiwavelength anomalous diffraction approach was chosen to 
solve the phase problem and the XPD structure. To achieve this taXPD was co
crystallized in the presence of 8I
furthermore the crystals were soaked with different heavy atom derivatives. These 
approaches did not result in high quality diffracting crystals with the additive bound 
to the protein. 
 
4.3.2 Crystallization of taXPD with DNA
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should separate the unbound DNA
approaches were performed in 
with different DNA substrates: ssDNA 10mer, ssDNA 22mer, B
substrate, CPD containing 25mer and 30mer and a dsDNA K10T/KU10T
The best diffracting crystals were obtained by incubating
taXPD in a stoichiometric ratio of 1.2:1 at RT for 30 min. Crystals were grown by 
vapor diffusion in hanging drops containing equal volumes of a protein
complex in 20 mM Tris (pH 8), 200 mM NaCl and 10 mM MgCl
solution consisting of -50 mM MES pH 6.5, 10 mM MgSO
KCl equilibrated against the reservoir solution 
 
4.3.3 Crystallization of faXPD
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4.4 TaXPD apo structure 
4.4.1 Data collection and structure solution of apo taXPD  
Prior to data collection, the crystals were cryoprotected by sequential transfer into 
mother liquor containing increasing amounts of glycerol in 5% steps to a final 
concentration of 30%. 
Table 4.1: Data collection and refinement statistics 
 
The R-factoris defined in 3.6.4. <I>/<σI> indicates the average of the intensity divided by its 
average standard deviation. Numbers in parentheses refer to the respective highest resolution data 
shell in each dataset. Phasing power is the mean standard value of the heavy atom structure factor 
amplitude divided by the lack of closure for anomalous (ano) and isomorphous (iso) data. Rfree is 
the same as Rcryst, but is calculated for 5% of the data randomly omitted from the refinement. Mean 
B-factor is the mean residual B-factor after TLS refinement. 
The crystals were flash cooled in liquid nitrogen, and data collection was 
performed at 100 K. Data sets were collected at beamline BM14 (European 
Synchrotron Radiation Facility [ESRF]) at wavelengths of 1.0 Å, 1.7 Å, 1.7367 Å, 
and 1.7419 Å (Table 4.1). All data were indexed and processed using Moslfm and 
Scala. The taXPD protein crystallized in space group P65 with one XPD molecule 
in the asymmetric unit. The structure was solved by Dr. Jochen Kuper by 
multiwavelength anomalous diffraction (MAD) using the anomalous Fe signal of 
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the endogenous FeS cluster in the protein as described in 3.6.2. The Fe sites were 
located using ShelxD and with the program Sharp phase improvement was 
achieved. The sub-structure solution of the cluster and the refinement was carried 
out at 4 Å resolution and the 4Fe4S cluster was treated as one “super-Fe atom” for 
phasing. The programs Solomon and Pirate were used for solvent flattening and 
phase extension to 3.6 Å. Arp/WARP was used to autotrace the solvent-flattened 
maps by using the low-resolution quick-build option. The obtained model was 
further extended manually by Prof. Hermann Schindelin and Prof. Caroline Kisker 
using O and Coot. The model was exposed to phase-restrained simulated 
annealing and maximum likelihood refinement using phenix.refine after assigning 
the maximum number of residues possible. This model was then further refined by 
cycling between manual model building and refinement using Refmac5 with TLS 
refinement. The final structure was refined at 2.9 Å resolution to an R-factor of 
0.209 and an Rfree of 0.287. The model contains residues 23-507 and 515-615 
(586 out of 602 residues) of the XPD construct with residues 20 to 22, 508 to 514, 
and 616 to 620 presumably disordered.  
 
4.4.2 Overall taXPD structure 
The taXPD structure consists of four distinct domains. Residues 23-87, 178-225, 
and 366-407 form domain 1, residues 88-177 form domain 2, residues 226-365 
form domain 3 whereas residues 408-615 form domain 4 (Figure 4.6). Domains 1-
3 together with α-helix α22 from domain 4 form a donut-shaped structure that 
contains a hole with a diameter of approximately 13 Å. The remainder of domain 4 
is positioned in front of the ring. The overall dimensions of the protein can 
therefore be separated into the donut with a width and height of 65 Å and 75 Å and 
a thickness of 29 Å. At the location of domain 4, the width of the ring is increased 
to 45 Å. In the context of the overall structure, domain 1 can be viewed as the core 
domain surrounded by the three other domains. Domains 2 and 3 are 
insertions,which emerge from domain 1. Domain 2 is inserted between β-strands 
β3 and β4, while domain 3 is inserted between α-helices α11 and α17. Domain 4 
is situated adjacent to domain 1 within the linear protein sequence. 
 
The motor domains 
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Domains 1 and 4 are the two motor domains of the protein which convert the 
energy of ATP-hydrolysis into motion. The tandem occurrence of both domains 
that have the classical RecA-like fold is present in all helicases of superfamilies 1 
and 2 (SF1 and SF2). The two domains can be superimposed with an rmsd of 2.4 

 
Figure 4.6: Overall structure of taXPD.(A) Front view of taXPD, with domain 1 in yellow, domain 
2 in cyan, domain 3 in green, and domain 4 in red. The FeS cluster is shown in all-bonds 
representation. The surface representation of taXPD is shown in grey. (B) view of arch domain. (C) 
view of the two motor domains. (D) view of the FeS domain. 
Å indicating their similarity. Motor domain 1 consists of seven β-sheets surrounded 
by seven α-helices. Motor domain 2 contains six β-sheets surrounded by seven α-
helices and two 310-helices. The putative ATP-binding site is formed by the 
interface between domains 1 and 4. Domain 1 contains helicase motifs I, Ia, II and 
III, whereas domain 4 harbors helicase motifs IV, V and VI. 
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The arch domain 
The antiparallel β-sheets 6, 7, 8 and 9 and the α-helices 12 to 16 form the arch 
domain and comprise a novel protein fold. The β-strands β6 to β9 form a β-bridge 
to domain 1. Furthermore the arch-domain contains two α-helical hairpins formed 
by α12 and α13 and α15 and α16, respectively. The interface of the two hairpins 
forms a hydrophobic core. SSM searches revealed no hit indicating the novelty of 
this protein fold. The interface of domains 2 and 3 is formed by 17 residues from 
each domain and buries 620 Å2. The interaction between the two domains is 
mainly mediated by hydrophobic interactions and four salt bridges between 
residues Lys323/Asp99, Arg335/Glu103, Arg235/Glu103 and Glu315/Lys111. 
 
The FeS cluster domain 
The core of the FeS domain is a 4Fe4S cluster which is coordinated by the four 
cysteines Cys92, Cys113, Cys128 and Cys164 (Figure 4.7). Three of these 
cysteines are located in loops whereas Cys113 is positioned within α-helix 5. The 
cluster is surrounded by six α-helices and two 310-helices. The domain is stabilized 
by hydrophobic interactions. Hydrophobic residues like Arg88, Tyr166, Glu167, 
Lys117 and Phe131 shield the cluster with their long side chains from the solvent. 
They all point into a basic groove which lies between domains 1 and 2 and could 
be a putative DNA binding site. Residues Arg88 and Tyr166 form a small basic 
pocket in this groove. A SSM search revealed that the transcription factor c-myb is 
the closest structural homolog to the fold of the FeS cluster although c-myb does 
not contain an FeS cluster. 
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Figure 4.7: FeS cluster.(A) 
times the standard deviation around the 4Fe4S cluster and the surrounding protein in grey, and at 
four times the standard deviation in blue. The cluster and the coordinating cysteines are shown in 
all-bonds representation. Secondary str
proximity to the 4Fe4S cluster. The cluster is shown as in (A), and residues Arg88, Tyr166, Lys117, 
Phe131, and Glu167 are shown in all
labeled in grey.(Wolski et al. 2008)
 
4.5 Model of faXPD based on taXPD
Figure 4.8: Model of faXPD.
3 in green and domain 4 in red. The FeS cluster is shown in all
orange. FaXPD is colored in blue.
Since there is no structure available for the 
structure was generated through homology modeling
))
SIGMAA weighted 2Fo-Fc electron density map contoured at one 
ucture elements are labeled in grey. (B)
-bonds representation, with secondary structure elements 
 
 
 
 taXPD is colored with domain 1 in yellow, domain 2 in cyan, domain 
-bonds representation and col
 
Ferroplasma acidarmanus
. For automated homology 
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modeling the ESyPred3D web server was used with the XPD structures 
Thermoplasma and Sulfolobus 
of the homology model and the taXPD structure reveals that
a quite similar overall fold as taXPD WT (Figure 4.8)
superposed with an rms deviation of 
coincides with the CD spectroscopy result which revealed a similar secondary 
structure in both XPDs. 
 
4.6 XPD–DNA binding model
Figure 4.9: Electro-static surface potential of taXPD. 
surface potential of taXPD. The surface potential has been calculated with Pymol/APBS at an ionic 
strength of 150 mM and is contoured at ±10kBT. The first view is the same
)#
(2VSF and 3CRV) as templates. The superposition 
 the faXPD model has 
. The two structures can be 
2 Å indicating a similar overall fold which 
 
Four different views of the electrostatic 
 as in F
from 
 
igure 4.6, A; the 
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arrows show the transition from one view to the other with the rotation indicated by the arrow. 
Putative DNA binding sites are marked by additional arrows.(Wolski et al. 2008) 
To obtain insight into the DNA binding mode of XPD, the electrostatic surface 
potential of the protein was calculated with Pymol/APBS at an ionic strength of 150 
mM (Figure 4.9). The surface potential indicates a positively charged path along 
domain 4, leading towards a highly conserved groove along domain 4 and domain 
1. This basic path protrudes through a pore formed by domain 1, the arch domain 
and the FeS domain as described above into a basic pocket behind the pore. 
Based on the calculations of the electrostatic surface potential (see Figure 4.9), 
mapping of highly conserved (yellow) and strictly conserved (green) residues on 
the XPD structure and the superposition with the structure of NS3 with ssDNA 
(see Apendix) a DNA-binding model can be proposed (Figure 4.10). The ssDNA 
passes through a conserved groove from domain 4 to the pore. The DNAprotrudes 
through the highly conserved hole into a basic groove in the FeS domain. This 
basic groove additionally harbors a narrow pocket formed by residues Arg88, 
Tyr166 and Tyr185 (Figure 4.10). This pocket is sufficient in size to accommodate 
purine and pyrimidine bases. This model is supported further byadditional peaks in 
the difference electron density maps which have a space of 6.5 Å between them. 
In DNA the space between the phosphates of the backbone is 6.4 Å (Figure 4.10). 
Since there is no phosphate present in the purification or crystallization conditions 
it could be possible that some DNA remained bound to the protein. 
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Figure 4.10: Hypothetical XPD-DNA model. Domain 1 is colored in yellow, domain 2 in cyan, 
domain 3 in green and domain 4 in red, respectively. (A) Overall view of XPD in complex with 
ssDNA. The model was obtained by superposition with the NS3 helicase in complex with ssDNA. 
Residual difference map peaks at 2.5 times the standard deviation are shown in blue, and peaks 
used for backbone phosphate positioning are numbered. Further extension of the ssDNA towards 
the hole was achieved by addition of B-form DNA. The DNA is shown with its backbone in orange, 
and the bases are shown in blue spokes. (B) Close up view of (A). (C) Surface representation of 
the XPD-DNA model. The DNA is shown as in (A), and the surface is colored according to 
sequence conservation, with green indicating strictly conserved, yellow highly conserved and gray 
residues that are not conserved. The DNA in this view emerges from the pore and fits nicely into 
the highly conserved pocket (indicated by the arrow), which could potentially play a role in damage 
recognition or which couples DNA binding to the FeS cluster. (D) Top view of the XPD-DNA model. 
For clarity, the top part of XPD has been removed to allow a view into the highly conserved groove, 
which leads the ssDNA towards the hole in the donut-shaped molecule.(Wolski et al. 2008) 
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4.7 taXPD-DNA complex 
4.7.1 Data collection and structure solution of taXPD with DNA 
Prior to data collection the crystals were cryoprotected by sequential transfer into 
mother liquor containing 30% MPD. The crystals were flash frozen in liquid 
nitrogen and data collection was performed at 100 K. The data set was collected 
at beamline BM14 (ESRF) at a wavelength of 0.972 Å and to 2.2 Å resolution. All 
data were indexed and processed using Mosflm and Scala. The crystal belong to 
space group P65 with unit cell dimensions of a=b= 79.1 Å and c=175.7 Å (Table 
Table 4.2: Data Collection and refinement statistis  
 
Values in parentheses refer to highest resolution shell. The R-factor is defined in 3.6.4. I/σI 
indicates the average of the intensity divided by its average standard deviation. Rfree is the same as 
R for the 5% of the data randomly omitted from refinement. B-factor analysis was performed on the 
residual B-factors after TLS-refinement. Ramachandran statistics indicate the fraction of residues in 
the favoured, allowed, and outlier regions of the Ramachandran diagram. 
4.6). The apo XPD structure (2VSF) was used as a model for molecular 
replacement which was performed with PHASER. To improve the model 
alternating rounds of manual model building in Coot and maximum likelihood 
refinement with Refmac5 were performed. The structure was refined at a 
resolution of 2.2 Å to an R-factor of 19.5 % and and Rfree of 25.1 % with good 
stereochemistry as indicated by the Ramachandran statistics (Rampage). 
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4.7.2 XPD-DNA structure
For protein expression a construct (
terminus was used, and therefore
observed. Furthermore four other 
observed. The largest electron density feature could be identified as four DNA 
bases. From the density the se
at the 5’-end of the used
end of the DNA points towards the solvent whereas the 3’
conserved pass leading through the protein. The protein
an accessible surface area of 370 Å
and non-polar residues. Trp549 forms a strong protein
interactions with the adenine base. Arg584 also mediates strong interactions with 
DNA. Arg584 interacts via hydrogen bonds with the phosphate backbone of the 
adenine and cytosine bases. The Arg584
interactions between Asp582 and Arg584.
Figure 4.11: The taXPD-DNA complex. 
domain 3 in green and domain 4 in red. The FeS cluste
DNA in green is shown in all
oligonucleotide visualized in the structure with its carbon atoms in green. Residues interacting with 
the DNA are shown with their carbon atoms in blue and hydrogen bonds are indicated by dashed 
black lines. 
The three remaining features in the electron density could be identified as sulfate 
molecules which originate from the crystallization solution. The first sulfate site is 
#(
 
taXPDT3) with additional residues at the N
 the electron density of this 
significant electron density features were 
quence could be mapped as TACG, which
 DNA substrate. The DNA is located at domain 4. The 5’
-end points towards the 
-DNA interface consists of 
2
. This interface consists in equal 
-DNA interaction by 
-DNA interaction is further stabilized by 
 
(A) Domain 1 is colored in yellow, domain 2 in cyan, 
r is shown in all-bonds representation. The 
-bonds representation. (B) Enlarged view showing the tetra
-
α-helix was 
 is found 
-
parts of polar 
pi-
 
-
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located in the arch-domain at α-helix α13. It is involved in crystal contacts. The 
second sulfate is located directly in a small pocket in the basic groove at the exit of 
the poreand forms hydrogen bonds with Tyr166, Lys170, Arg88 and His198. The 
third sulfate molecule is located in the ATP-binding pocket of the Walker A motif. 
 
4.8 Sequence alignment of XPD from different organisms 
 
Figure 4.12: Sequence alignment. Sequencealignment of five different XPD proteins. From top to 
bottom: XPD from T.acidophilum, human, mouse, Arabidopsis thaliana, and Saccharomyces 
cerevisiae. Secondary structure elements are indicated above the sequence and are color coded 
according to their domains; arrows indicate β-strands and coils α-helices. Helicase motifs are 
shown as grey boxes. Mutations leading to xeroderma pigmentosum, Cockayne syndrome or 
trichothiodystrophy are indicated below the sequence and are colored in blue, green and grey, 
referring to their occurrence in trichothiodystrophy, xeroderma pigmentosum or xeroderma 
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
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pigmentosum/Cockayne syndrome patients, respectively. Conserved residues are boxed and 
strictly conserved residues are shown in white with a red background. The four cysteines that 
coordinate the 4Fe4S cluster are highlighted in green surrounded by thick blue boxes. (Wolski et al. 
2008) 
The sequence alignment in Figure 4.12 shows a comparison of XPDs from 
different organisms. The secondary structure elements and the helicase motifs are 
mapped on the alignment. This alignment reveals a high sequence homology in 
the helicase motifs. Furthermore, the Iron-sulfur cluster coordinating cysteines are 
conserved in the XPDs of all organisms shown in Figure 4.12 from Thermoplasma 
acidophilum to human. Most of the mutations which lead in humans to the 
diseases xeroderma pigmentosum, trichothiodystrophy and xeroderma 
pigmentosum/ Cockayne syndrome are strictly conserved residues in all 
organisms shown with exception of R601W, R601L and C259Y. This indicates that 
taXPD serves as a good model for human XPD due to the high sequence 
homology. 
 
4.9 Site-directed mutagenesis 
Based on the taXPD apo structure (Figure 4.6), the DNA binding model and the 
sequence alignment different XPD mutants were generated by site-directed 
mutagenesis of the taXPDT3 construct as described in 3.3.1. These mutants 
provide a basis to assess where the path of the translocated strand is located and 
identify functionally important regions of the protein that also apply to eukaryotic 
XPDs. The mutants can be divided into different groups: first there are the cluster 
mutants C92S, C113S, C128S and C164S where the FeS cluster coordinating 
cysteine is replaced by a serine; secondly there are the disease related mutations 
R88H, R567W, D582N and R584E which lead in humans to trichothiodystrophy 
and xeroderma pigmentosum, respectively. To find possible regions on both sides 
of the protein where double stranded DNA is separated a third group of mutants 
was created including M115R, R118A, F133A, F538S, Y545S, W549S and 
Y545S/W549S. Finally a fourth group of mutants was designed including mutants 
of conserved and strictly conserved residues: Y46A, R59A, R59E, E107A, Y166A, 
K170A, K170E, Y185A, Y166A/Y185A, E315A, F326A and Y425E. 
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Expression of the mutants was 
expression and purification of M115R, C128S, C164S, E315A and Y166A/Y185A 
revealed no overexpression or the protei
procedure. Therefore they were not pursued further.
 
4.10 ThermoFluor of taXPD mutants
After the expression and purification of the taXPD
the taXPD pointmutants have the same 
taXPD WT. To this end
3.4.4. As depicted in Figure 4.13
unfolding curve indicates that the protein unfolds 
same melting temperature as taXPD WT 
Y166A/Y185A, Y545S/W549S and W549S. The mutants Y46A, R59A, R59E, 
R88H, C92S, C113S, F133A, Y166A, Y185A, F326A, Y425E, F538S and R584E 
are more stable and unfold at slight
and the R59E differ in the unfolding transition. Their unfolding curves show a 
biphasic behavior indicating a slightly different fold as taXPD WT. Proteins with a 
different unfolding transition as taXPD WT 
exception of C113S. 
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performed analogously to XPD WT. The 
ns were not stable during the purification 
 
 
variants it had to be 
overall conformation and stability 
 a ThermoFluor assay was performed as desc
 taXPD WT unfolds at 51°C. The shape of the 
with one steep trans
was obtained for the mutants K170A, 
ly higher temperatures. The C113S, Y185A 
were not used for further analysis
shown that 
as the 
ribed in 
ition. The 
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Figure 4.13:Unfolding Curves of taXPD WT (blue) and taXPD variants. 
 
4.11 Biolayer Interferometry identifies residues which are involved in DNA 
binding 
To identify residues which are important for ssDNA binding Biolayer Interferometry 
assays were performed in the Octet reaction buffer as described in 3.4.6. The 
measurements were performed at 30°C with different protein concentrations and 
different protein batches. To compare the DNA binding properties of taXPD 
variants 100 nM of a ssDNA 50mer was immobilized at the sensor tip. The data 
was analyzed using the Octet RED data analysis software and the curves were 
fitted using the 1:1 binding model. 
Comparable to XPD from Sulfolobus acidocaldarius(Fan et al. 2008) taXPD 
displays a binding constant (KD) of 61 nm for the used substrate which indicates a 
high affinity for this DNA. 
All the disease related mutations show reduced DNA binding ability, however they 
differ in the strength of the phenotype from 10-fold for D582N, 6-fold for R567W, 5-
fold for R88H and a 37-fold reduction of the KD for R584E. Y46A is the only mutant 
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Figure 4.14: DNA binding properties of taXPD variants. The KD values of different taXPD 
mutants are plotted in a logarithmic scale. The mutants are colored with respect to their KD. Blue 
colored are KDs with 10-8M, green with 10-7 M, orange with 10-6 M and red with 10-5 M. The error 
bars show the standard error. 
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Table 4.3: DNA binding properties of 
Y545S/W549S
The values are color coded with respect to the K
blue, KDs with 10-7 M are colored in green, K
are colored red. 
Figure 4.15: KDs of taXPD variants. 
colored with respect to their K
colored in orange and 10-5 M 
which shows with 48.5 nM a comparable K
cluster mutants C92S and C113S show a 2
#)
taXPD variants. 
KD 
Wildtype 61 ± 3.51 nM 
Y46A 48.5 ± 7.79nM 
R59A 385 ± 83.7nM 
R88H 299 ± 57.9 nM 
C92S 130 ± 6 nM 
E107A 403 ± 79.9 nM 
C113S 210 ± 36.8 nM 
R118A 400 ± 87.5 nM 
F133A 353 ± 43.1 nM 
Y166A 146 ± 67.8 nM 
K170A 2.12 ± 0.4 µM 
K170E 345 ± 105 nM 
Y166A/Y185A 3.16 ± 0.37 µM 
F326A 594 ± 48.9 nM 
Y425E 3.32 ± 0.85 µM 
F538S 172 ± 41.2 nM 
Y545S 251 ± 53.8 nM 
 2.67 ± 0.42 µM 
W549S 28.3 ± 22.8 µM 
R567W 367 53.3 nM 
D582N 697 ± 78.6 nM 
R584E 2.26 ± 0.37 µM 
D. WT binding properties with 10
Ds with 10-6 M are colored orange and K
Surface representation of taXPD. TaXPD variants are 
D. 10-8 M is colored in blue, 10-7 M is colored in green, 10
is colored in red. 
D as taXPD WT (61 nM). The two 
- to 3-fold reduction of the K
-8M are colored in 
Ds with 10-5 M 
 
-6
 M is 
D. The 
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strongest effects on ssDNA-binding were observed in the second motor domain 
(domain 4) where Tyr425, Phe538, Tyr545, Trp549, Arg567, Gln582 and Arg584 
are located. The W549S mutant even shows a 500-fold reduction in the DNA 
binding ability indicating an important role in protein-DNA interaction for Trp549. 
Interestingly the Y545S/W549S doublemutant has a lower KDcompared to W549S 
and therefore displays a better DNA binding ability. As displayed in the DNA 
binding model ssDNA continues from domain 4 between the two motor domains 
as indicated by the reduced affinity of the R59A (6-fold) variant. Arg59 is a strictly 
conserved residue located in helicase motif Ia. The side chain of Arg59 points into 
a cleft at the interface of the two motor domains which was proposed to 
accommodate ssDNA. This path protrudes through the pore formed by motor 
domain 1, the arch domain and the FeS domain as mentioned above. To verify if a 
DNA strand is passing through the pore, five variants were designed, within or in 
close proximity to the pore, namely R88H, E107A, Y166A, Y166A/Y185A and 
F326A. All five variants show a reduced binding affinity indicating that these 
residues are involved in protein-DNA interactions. These observations support the 
implication that the translocating DNA strand is passing through the pore. As 
suggested by the DNA binding model the translocated DNA strand most likely 
interacts with residues located in a basic groove that is formed by two α-helices (5 
and 8) from the FeS domain and α-helix 10 from domain 1 since R118A, F133A 
and K170A show a decreased affinity. Taken together the location and binding 
affinities of the different variants suggest that a path of ssDNA leads from domain 
4 along a groove formed by the two motor domains through the pore and thereby 
covering the complete length of the protein which could accommodate around 20 
bases of DNA. 
 
4.12 taXPDs ATPase activity is stimulated by ssDNA 
To investigate which regions of taXPD are important for ATPase activity ATPase 
assays were kindly performed by Gudrun Michels. For XPD from Sulfolobus 
acidocaldariusit was demonstrated that its ATPase activity is stimulated by ssDNA  
(Rudolf et al. 2006). Therefore taXPD WT and mutants were analyzed with respect 
to their ATPase activity stimulated by ssDNA. ATPase assays were performed as 
described in 3.4.5. In absence of ssDNA the ATPase activity is hardly detectable 
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(data not shown). Upon addition of ssDNA (0.5 µM) the specific activity of taXPD 
WT is 2.0 mol ATP*s-1*mol-1 XPD (Figure 4.16). This value is four times higher 
than that determined for XPD from Sulfolobus acidocaldarius(Fan et al. 2008). 
Based on the results of the ATPase assays the taXPD variants can be divided in 
two different groups. Group I consists of Y46A, R59A, Y425E, Y545S/W549S 
W549S, D582N and R584E whereas group II contains R88H, C92S, E107A, 
C113S, R118A, F133A, Y166A, Y166A/Y185A, K170A, K170E and F326A. Group 
I variants are located in the two motor domains and thereby in front of the pore 
with respect to the DNA binding model. Variants of group II are located in the arch 
domain and in the FeS domain and thus behind the pore. 
 
Figure 4.16: ATPase activity of taXPD WT and variants. 
All group I variants display a significantly decreased DNA binding ability which 
comes along with an impaired ATPase activity. W549S displays the most severe 
phenotype with no measureable ATPase activity and a strong impaired DNA 
binding ability. Mutants which are located in front of the pore show at least a 
tenfold reduction in ATPase activity. Interestingly, mutants which are positioned 
within or behind the pore display a different phenotype. In these variants the 
ATPase activity remains high although ssDNA-binding is impaired. However, there 
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is an exception, R118A displays a reduced ATPase activity. The group II variant 
Y166A is located directly in the pore, it shows an increased activity of 4.7 mol 
ATP*s-1*mol-1 compared to 2.0 mol ATP*s
F326A, R88H and E107A variants a
activity with 50% increase compared to taXPD WT. The activity of F133A is, 
however, comparable to taXPD WT.
 
4.13 taXPD is an ATP-dependent 5’
R584 are important for helica
To demonstrate that taXPD is an active 
as described in 3.4.7. The results reveal that XPD unwinds 5’
in an ATP-dependent manner as shown in F
To identify regions of the protei
helicase assays with the taXPD variants were performed by Dr. Jochen Kuper and 
Gudrun Michels. Helicase assays were conducted as described in 3.4.8. All group 
I variants (R59A, Y425E, W549S, D582N and R
unwinding ability which is in line with defects in DNA binding and ATPase activity. 
The two disease related variants D582N and R584E which lead in humans to XP 
display no helicase activity (Figur
Figure 4.17: Helicase activity of taXPD WT.
more complex. Although they show defects in DNA binding 
activity the variants R88H and E107A display a helicase activity comparable to 
taXPD WT. The two variants F133A and 
helicase activity which is interesting since they are impaired in DNA binding. 
#-
-1*mol-1 for taXPD WT. K170A, 
lso display a significantly increased ATPase 
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Furthermore K170A displays with a 3
highest helicase activity. S
can result from the higher turnover rate for ATP. In contrast the Y166A and F326A 
variants also display an increased ATPase activity yet either show no (Y166A) or a 
highly reduced (F326A, 20
Figure 4.18: Helicase activity of taXPD variants.
 
4.14 taXPD and faXPD 
higher affinity as non-damaged bubble substrates
Different DNA substrates were tested in Biolayer Interferometry DNA binding 
assays with taXPD WT and f
crystallization. 100nM of the particular su
The measurements were carried out as described in 3.4.6 in
buffer. The experiment was performed at 30°C with 
concentrations and different protein batches. The data was analyzed usi
Octet RED data analysis s
model. 
Different DNA lengths were tested from 
assays revealed that a ssDNA 50mer 
ssDNA substrate tested 
different bubble substrates and different d
#7
-fold increase compared to taXPD WT the 
ince K170A also shows elevated ATP
-fold) helicase activity. 
 
bind fluorescein-containing bubble substrates with a 
 
aXPD to identify an optimal substrate for 
bstrate was immobilized at the s
 the
oftware and the curves were fitted using the 1:1 binding 
a 10mer up to a 50mer. DNA bindi
displays a KD of 61 nM and is the best 
(Weller 2010). A ssDNA 50mer, a 5’-overha
amages were compared subsequently 
ase activity this 
 
ensor tip. 
 Octet reaction 
different protein 
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ng 
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(Figure 4.19). TaXPD WT shows a slight preference for small 8 nucleotide bubbles 
compared to the larger 16 nucleotide bubbles. As a damage fluorescein and CPD 
were chosen since it was shown for faXPD that it is stalled by a CPD lesion 
(Mathieu et al. 2010). Interestingly the fluorescein containing bubble substrates 
have a 4-fold lower KD as the CPD containing bubble substrates (Figure 4.19). 
taXPD WT also shows a preference for the 8 nucleotide fluorescein containing 
bubble substrate compared to the non-damaged and the 5’-overhang substrate. 
Interestingly, the CPD containing substrates display the worst affinity. 
 
Figure 4.19: DNA binding behavior of taXPD WT to different DNA substrates. 
 
Figure 4.20: Comparison of DNA binding properties of taXPD WT and faXPD. 
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Furthermore the DNA binding properties of taXPD WT and faXPD were compared 
(Figure 4.20). Therefore a ssDNA 50mer and 16 nucleotide bubble substrates with 
and without a damage were chosen. FaXPD shows as taXPD WT a preference for 
a fluorescein containing bubble substrate. TaXPD WT binds 4-fold better to the 
ssDNA 50mer as faXPD. FaXPD and taXPD WT bind better to non-damaged 
bubble substrates as to CPD-containing bubble substrates. Taken together the 
KDs for all substrates show that taXPD WT and faXPD bind with high affinity to the 
substrates. However both XPDs show a preference for the fluorescein-containing 
substrate. 
The association and dissociation curves for taXPD WT and faXPD reveal for all 
substrates a similar kon and koff, respectively. The kon is approximately 103 and the 
koff approximately 10-5 for all the different substrates. This indicates that all 
substrates are bound in a similar way. Since for the bubble substrates there are 
two possible DNA binding sites it was also tried to fit with a 2:1 binding model, 
however only the 1:1 binding model revealed good fits for the association and 
dissociation curves. 
 
4.15 Iron sulfur cluster analysis 
4.15.1 Electron paramagnetic resonance studies 
Iron-sulfur (FeS) clusters can have different redox states: [4Fe4S]2+and the 
oxidized forms [4Fe4S]3+and [3Fe4S]1+. To further analyze the4Fe4S cluster of 
taXPD electron paramagnetic resonance studies were performed in collaboration 
with Lisa Engstrom a graduate student in Sheila David’s laboratory, UC Davis, 
USA. A [4Fe4S]2+ cluster shows no EPR signal, it is EPR silent, whereas the 
oxidized [3Fe4S]1+ cluster shows a significant signal at 2.02 g. EPR analysis was 
performed as described in 3.4.9. First XPD was treated with different oxidants.  
 
Table 4.4: Iron-sulfur cluster properties of taXPD 
Oxidant [oxidized cluster] % oxidation 
Co-(phen)33+ 13 µM 26 % 
Co-(5-Cl-phen)33+ 6.7 µM 13 % 
Superoxide 33 µM 66 % 
"
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Untreated taXPD WT contains a [4Fe4S]
clusters oxidized. Only treatment with Co
superoxide resulted in a [3Fe4S]
in the presence of these agents. Superoxide seems to be the best oxidantsince 
66% of the clusters are oxidized compared to 26% and 13% for Co
Co-(5-Cl-phen)33+, respe
of taXPD is resistant to oxidization by Ir(Cl)
nitric oxide since taXPD is EPR silent in t
4.21). The FeS cluster could 
dithionite (spectra not shown) indicating that taXPD behaves like a HiPIP and not 
like Ferredoxin. 
Figure 4.21: EPR spectra of taXPD WT
Co(phen)33+ in red, with Co(5-
WT with Nitric Oxide (blue), Peroxynitrite (red), Superoxide (green) and H202 (purple). 
of taXPD WT and different DNA substrates. Without DNA (blue), ssDNA (
forked (purple), F2140 (cyan) and F1522 (orange). 
substrates with and without ATP. F2140 colored in blue, F1522 colored in red, F2140 with ATP 
colored in green and F1522 with ATP colored in pur
4
2+
 cluster indicated by only 2% of the 
-(phen)33+, Co-(5
1+
 cluster signal indicating that taXPD 
ctively (Table 4.4, Figure 4.21). However,
6
2-
, ferricyanide, H2O2
he presence of these oxidants (F
not be reduced to a [4Fe4S]1+ cluster by sodium 
. (A) Spectra of taXPD WT without oxidant in blue, with 
Cl-phen)33+ in green and with Ir(Cl)62- in purple. (B)
(D) Spectra of taXPD WT and different DNA 
ple. 
-Cl-phen)33+ and 
is oxidized 
-(phen)33+ and 
the FeS cluster 
,peroxynitrite and 
igure 
 
 Spectra of taXPD 
(C) Spectra 
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To further characterize the properties of the FeS cluster taXPD WT was incubated 
with different DNA substrates and then treated with Co-(5-Cl-phen)33+ prior to EPR 
analysis. In the presence of ssDNA 7% of the clustersare oxidized compared 
to13% in the sample without DNA (Table 4.5, Figure 4.21). In the presence of 
dsDNA 13% of the clusters are oxidized. It was also tested what effect the 
presence of ATP and damage-containing substrates have on the cluster (Table 
4.5). 
In the presence of DNA and ATP and in the presence of Fluorescein containing 
DNA the cluster is oxidized more readily. In the presence of the 5’-overhang 
substrate mjd1/ndb the cluster is almost EPR silent, only 2% are oxidized. By 
addition of ATP the oxidation of the cluster increases to 20%. With a damage on 
the translocating strand (F2140) 42% of the cluster is oxidized and by ATP 
addition this increases to 50%. When the damage is located on the non-
translocating strand (F1522) 25% of the cluster is oxidized. In the presence of ATP 
it is increased to 32%. It seems that the substrate shields the cluster from oxidizing 
agents and the addition of ATP leads to a conformational change which leads to a 
higher accessibility of the cluster for the oxidizing agent. In addition the fluorescein 
on either of the two strands leads to a structural change around the cluster which 
seems to make it more accessible for the oxidant. 
Table 4.5: Iron-sulfur cluster properties of taXPD in presence of DNA 
 
 
4.15.2 Iron-sulfur cluster analysis of taXPD variants 
To analyze the FeS cluster properties of selected taXPD variants the EPR was 
performed as described in 3.4.9. C92S and C113S were chosen because the 
cysteine residues coordinate the FeS cluster. Arg88 stabilizes the cluster and 
DNA substrate [oxidized cluster] % oxidation 
ssDNA 40mer 3.7 µM 7 % 
dsDNA 30mer 6.7 µM 13 % 
Mjd1/ndb 1 µM 2 % 
Mjd1/ndb & ATP 10 µM 20 % 
F2140/NDB24 21 µM 42 % 
F2140/NDB24 & ATP 25 µM 50 % 
F1522/NDB40 13 µM 25 % 
F1522/NDB40 & ATP 16 µM 32 % 
"


interacts with DNA; furthermore the 
trichothiodystrophy in humans. 
 
Table 4.6: Iron-sulfur cluster properties of taXPD variants
mutant 
R88H XPD 
R88H & Co(5-Cl
C92S 
C92S & Co(5-Cl
C113S 
In untreated taXPD WT only 2% of the FeS cluster is oxidized to a [3Fe4S]
cluster, for the C92S variant it is 27% and for the C113S mutant it is 90% 
indicating that the cluster in C92S and C113S is 
Figure 4.22). However the R88H mutant is similarto
cluster oxidized. In the presence of Co
and C92S even by 75%. This indica
C113S is not as stable as in taXPD WT and in C113S even only a [3Fe4S]
cluster is present. 
4
R88H variant (R112H in human XPD) 
 
 
[oxidized cluster] % 
oxidation
0 µM 0 %
-phen)33+ 31 µM 27 %
14 µM 27 %
-phen)33+ 38 µM 75 %
10 µM 90 %
not fully coordinated (Table 4.6, 
 taXPD WT with 0% of the 
-(5-Cl-phen)33+ R88H is oxidized by 27% 
tes that the cluster in the variants C92S and 
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Figure 4.22: EPR Spectra of taXPD variants. (A) Spectrum of R88H colored in blue, R88H with 
Co-(5-Cl-phen)33+ colored in red. (B) Spectrum of C92S colored in blue, C92S with Co-(5-Cl-
phen)33+ colored in red. (C) Spectrum of C92S colored in blue and spectrum of C113S colored in 
red. 
4.15.3 taXPD WT shows reduced helicase activity in the presence of 
oxidizing and reducing agents 
To investigate whether an intact 4Fe4S cluster is needed for helicase activity or if 
taXPD is also active when it contains a 3Fe4S cluster helicase assays were 
performed in the presence of oxidizing and reducing agents. The assays were 
conducted as described in 3.4.8 with slight modifications. The following buffer was 
used 20 mM Tris (pH 8.5), 10 mM NaCl, 5 mM MgCl2, 1 mM EDTA and taXPD, 
DNA and oxidizing and reducing agents were used in the following concentrations 
500 nM, 50 nM and 2.5 µM, respectively. The measurements were carried out at 
37°C. 
XPD WT Superoxide Sodium dithionite Ferricyanide Co-5-Cl(phen)
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Figure 4.23: Helicase activity of taXPD WT in the presence of oxidizing and reducing agents. 
Preliminary data revealed that treatment by superoxide, sodium dithionite, 
ferricyanide and Co-(5-Cl-phen)33+ leads to a 50-fold decrease in helicase activity 
(Figure 4.23). However, treatment with sodium dithionite and ferricyanide didn’t 
show an effect in EPR whereas treatment by superoxide and Co-(5-Cl-phen)33+ 
resulted in an oxidation to a [3Fe4S]1+ cluster. These helicase assays have to be 
further investigated and verified. 
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4.15.4 XPD is folded properly in the presence of different oxidants and 
reducing agents 
To verify that the reduced helicase activity of taXPD WT in the presence of 
different agents is not due to a 
spectroscopy was performed as depi
show that untreated XPD is properly folded in an 
XPD with superoxide, ferricyanide, sodium dithionite and Co
no effect on the overall fold of the protein indicating that these agents do not harm 
the protein which is in line with missing junk
conformational change without change of the secondary structure
detectable by CD spectroscopy.
Figure 4.24: CD spectra of taXPD treated with different agents. 
black. Superoxide, Ferricyanide, Sodium dithionite and Co
in red, green, blue and orange, respectively. 
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partially or completely unfolded
cted in 3.4.3. The CD spectra (Figure 4.24
α/β-architecture
-(5-Cl
-iron peaks in EPR. However a 
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5 Discussion 
5.1 The XPD crystal structure 
XPD is a 5’-3’helicase belonging to the superfamily 2 (SF2)(Singleton et al. 2007). 
As a subunit of TFIIH XPD functions in nucleotide excision repair and transcription 
(Coin et al. 1998). Because of the high sequence homology to eukaryotes 
Thermoplasma acidophilum was chosen as a model organism to obtain insights 
into the human NER pathway and the XPD helicase in particular. The function of 
XPD in archaea still remains unclear. 
In this work the structure of apo taXPD was solved, determined by 
multiwavelength anomalous diffraction using only the endogenous iron of the iron 
sulfur cluster. Size exclusion chromatography revealed that XPD is a monomer in 
solution as reported previously (Rudolf et al. 2006). As a subunit of TFIIH XPD 
interacts with p44, however p44 is not present in archaea. Therefore it is not 
remarkable that in contrast to human XPD the archaeal homologs lack p44 
interacting residues at its C-Terminus. XPD contains four domains. The two RecA-
like domains which are the motor domains of the protein and two insertions into 
motor domain 1, the arch-domain and the FeS domain. Domain 1 together with the 
two inserted domains form a donut-shaped structure with a pore in the middle.  
Superposition of XPD from Sulfolobus acidocaldarius und taXPD revealed that 
both proteins display a four domain organization (Figure 5.1). They can be 
superposed with an rms deviation of 3Å indicating structural similarity, however the 
sequence identity is with 19% relatively low, but all disease related mutations are 
included in the 19%. The major difference between the two structures is the size of 
the pore. In taXPD the pore has a diameter of approximately 13 Å whereas the 
pore in saXPD only has a diameter of 8 Å. Therefore the pore in taXPD is 
sufficient in size to accommodate ssDNA whereas the pore size of saXPD is too 
small (Figure 5.1). The difference in pore size is achieved by a different positioning 
of the arch and theFeS domain relative to each other. This variation could be 
mediated by domain 4. Helix α22 from domain 4 would push the β-bridge of the 
arch-domain leading to a 10˚ tilt in α22. Furthermore saXPD displays a more 
closed conformation of the two motor domains. Therefore this mechanism could 
link ATP-hydrolysis to pore size dynamics. This is also supported by a normal 
mode analysis which reveals that movement of the tw
)'
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effect on the pore. Interestingly, XPD has to open up when it acts on its natural 
substrate. This could be achieved by a transient opening 
FeS domain which is in line with all three DNA binding models 
et al. 2008). Moreover single 
 
Figure 5.1: Superposition of taXPD and saXPD. 
in cyan and green, respectively.The XPD helicaseHelix 
highlighted by an arrow. The FeS andarch domain of saXPD are shown in blue and dark green, 
respectivley, and the helixcorresponding to helix 
cluster of taXPDis shown in orange. Domains 3 and 4 are colored in dark grey (taXPD) and 
grey(saXPD), respectively. (A)
taXPD and (D) the pore of saXPD.
 
XPD can bypass SSB proteins indicating a highly dynamic enzyme 
2009). Our biochemical data combined with the structure of the XPD
complex specifies the path of and polarity of the translocated strand according to 
the helicase framework. 
pointing towards the solvent and the 3’
4-
between
(Fan et al. 2008
moleculestudies showed that during translocation 
The FeS and arch domain of taXPD are colored 
α22 of domain 4 is colored in red and 
α22 from taXPD is colored in salmon. The FeS 
 Front view, (B) top view. (C) Surface representations of thepore of 
 
The DNA is bound at domain 4 with the 5’
-end pointing towards domain 3. 
 the arch and 
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Based on the XPD structures several questions arise: whereis the DNA bound? 
Where is DNA separated? Which residues are important for helicase functionality? 
Where are the disease causing mutations located in the tertiary structure? What is 
the role of the FeS cluster? How is damage verification achieved? These 
questions were addressed in the present work and are discussed here. 
 
5.2 Disease causing mutations 
XPD harbors phenotypes of three different diseases and is part of at least three 
different complexes TFIIH, CAK/XPD and MMXD. XPD is therefore involved in 
different cellular processes. TFIIH in humans is involved in nucleotide excision 
repair and transcription initiation as a general transcription factor for RNA 
polymerase II(Svejstrup 2002).XPD not only forms a complex with CAK in TFIIH 
but also with CAK alone(Ito et al. 2010). As part of a complex with CAK XPD may 
be involved in cell cycle regulation and as part of the MMXD(MMS19-MIP18-
XPD)complex in chromosome segregation (Ito et al. 2010). XPD thereby has at 
least three different interaction partners. The interaction of p44 with XPD in TFIIH 
stimulates XPDs helicase activity (Coin et al. 1998). XPD interacts in TFIIH but 
also by itself with the CAK subunit MAT1 (Reardon et al. 1996), (Drapkin et al. 
1996) and the MMXD subunit MMS19 (Ito et al. 2010). Mutations in XP-D can 
therefore lead to different effects. The first group of mutations can lead to an 
impaired interaction with p44 or MAT1 or MMS19 and thereby affecting XPDs 
activity in an indirect way. In the case of p44 and MAT1 this can also lead to a 
destabilization of the TFIIH core (without the CAK subunits) or the entire TFIIH 
complex. Furthermore the point mutants can affect the activity of XPD directly. 
Based on the structure the phenotype of mutations leading to xeroderma 
pigmentosum, Cockayne syndrome and trichothiodystrophy can be rationalized on 
a molecular level unparalleled so far. Mutations leading to xeroderma 
pigmentosum such as G47R, D234N and R666W (corresponding to G32R, D211N 
and R567W in taXPD) are located in helicase motifs I, II and VI (Figure 4.12), 
respectively and affect DNA and ATP binding thus inactivating the enzyme. This is 
also supported by biochemical data of the taXPD R567W variant which displays 
impaired DNA binding. However point mutations within other regions have quite 
distinct effects (Figure 5.2). 
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
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Figure 5.2: Mutants leading to xeroderma pigmentosum, Cockayne syndrome and 
trichothiodystrophy. XPD is shown in ribbon presentation and color coded as in Figure 4.6. Point 
mutations leading to either XP, XP/CS or TTD are shown in space-filling representation and are 
labeled according to the disease they cause in humans, black (XP), green (XP/CS) and blue (TTD). 
In humans the replacement of Arg112 (Arg88 in Thermoplasma acidophilum) by 
an histidine leads to trichothiodystrophy (Lehmann 2001). Arg88 points into a 
pocket formed by the residues Tyr166 and Tyr185. This pocket can directly 
interact with DNA. Arg88 is in close neighborhood of Cys113 an Iron-sulfur-cluster 
coordinating residue. Arg88 stabilizes this cluster by a hydrogen bond. 
Furthermore with its long side chain it protects the cluster from solvent exposure. 
The mutation to a histidine at this position leads to steric clashes and thereby to a 
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Figure 5.3: Zoom into the FeS cluster domain
indicated by blue dashes. (B) 
variant R88H. 
 
destabilization of the protein. Moreover the R112H 
chain which cannot donate a hydrogen bond 
destabilization. For the corresponding K84H variant from 
acidocaldarius it was demonstrated that the mutation has no affect on the ATPase 
activity and DNA binding
al. 2006), (Liu et al. 2008
phenotype (Dubaele et al. 2003
behavior. There is also no effect on ATPase activity, the DNA binding ability is 
moderately impaired, however the R88H variant is still helicase active
be due to a more stable FeS cluster in 
the human and Sulfolobus acidocaldari
might be an additional important role in damage verification related to this 
particular residue.  
In humans the variant 
Thermoplasma acidophilum
the arch domain are stabilized by a hydrophobic core. Ala236 points into this 
hydrophobic core. An exchange to a much larger tyrosine leads to steric clashes 
thereby destabilizing the entire domain.
The four mutations D673G, G675R
G576R, D582N and R584E in 
-	
. (A)Arg88 is shown in sticks. H
Similar view as in panel (A) for the trichothiodystrophy
variant provid
to Cys113 
 ability, however the helicase activity is affected 
). The R112H variant in humans shows the same 
). The taXPD variant displays a slightly different 
Thermoplasma acidophilum
usXPD protein. As discussed later on there 
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located in the C-terminal motor domain 2 and fulfill important structural roles or are 
involved in DNA interactions. Furthermore it was demonstrated that XPD interacts 
via its C-Terminus with p44 (Coin et al. 1998). G575R was analyzed with respect 
to its p44 interaction which revealed that this interaction is severely impaired (Coin 
et al. 1998). However in archaea there is no p44 homolog and therefore it is not 
surprising that XPD lacks residues at its C-Terminus which are important for p44 
interaction. Asp574 interacts with Arg570 (Arg669 in human XPD) thereby 
stabilizing the transition between α-helix 24 and β-strand β16. A replacement of 
glycine in residue 576 by an arginine would lead to a destabilization of domain 4 
since Gly576 points towards two hydrophobic residues and a much larger amino 
acid would increase the distance to these residues. Asp582 interacts with the 
strictly conserved residue Arg584 (corresponds to Arg683 in humans) which itself 
interacts with the two residues Asp426 and Phe527. However, our ThermoFluor 
data indicate that the D582N and the R584E variants have no effect on the 
stability of the protein and the exact role for the disease phenotype has to be 
elucidated in future studies. 
It was shown that the function of MMXD in chromosome segregation is affected in 
XP, and CS cells but not in TTD cells (Ito et al. 2010). The interaction of MMS19, a 
subunit of the MMXD complex, and XPD is mediated by residues 438-637 
indicated by pull down assays (Ito et al. 2010). However, this interaction can be 
affected by different mutations which are located in the region important for the 
interaction. Y542C and G602D (Tyr458 and Gly504 in Thermoplasma 
acidophilum) lead to XP and XP/CS, respectively. The two residues are very close 
to each other in the structure. Tyr458 is located in α-helix 20 of domain 4. It forms 
hydrophobic interactions with Val501 (Val599 in humans) which is a strictly 
conserved residue. The exchange from tyrosine to a cysteine would weaken the 
Tyr458/Val501 interaction. Gly504 is located between the two β-strands β14 and 
β15 in domain 4. A replacement of the glycine by an aspartic acid would lead to 
steric clashes with residue Tyr458. The mutations Y542C and G602D could 
therefore lead to an impairment of the MMS19-XPD interaction by affecting the 
interaction interface of the two proteins and therefore lead to an abnormality in 
chromosome segregation (Ito et al. 2010). However it was shown by Ito et al. that 
G602D did not affect the activity to bind MMS19(Ito et al. 2010), but it would be 
possible that the mutations affect somehow the enzymatic activity of XPD. These 
)'

-$

findings suggest that abnormalities in the function of MMXD due to the XPD 
mutations lead to aneuploidy and /or cell death (Ito et al. 2010) and might be 
mediated by a difference in XPD’s activity. 
From this analysis it can be concluded that mutations leading to XP affect the DNA 
and ATP binding ability, whereas mutations leading to XP/CS affect the flexibility 
between the two motor domains and mutations leading to TTD affect the overall 
stability of XPD. Furthermore the mutations can affect the enzymatic activity of 
XPD by an impairment in the interaction of XPD with MMS19 and p44. 
 
5.3 Conclusions from the mutagenesis studies 
The XPD-DNA complex structure revealed that Trp549 interacts with DNA forming 
pi-stacking interactions. Therefore it is not surprising that when mutated to a serine 
the DNA binding ability is severely impaired. Y545S and F538S show a similar 
phenotype with reduced DNA binding ability and impaired helicase and ATPase 
activity. All three residues are located in a region in domain 4 with several 
hydrophobic residues (Figure 5.4). Trp549 is not located in a strictly conserved 
region, Tyr545 and Phe538 however are conserved. Moreover neighboring amino 
acids are highly conserved and could fulfill in eukaryotes similar roles as Trp549. 
For example a phenylalanine (Phe652 in human XPD) which is highly conserved 
and located three residues C-terminally. 
The two variants D582N and R584E (correspond to D681N and R683W/Q in 
human XPD) which cause XP in humans show severe effects in DNA binding, 
ATPase activity and in the ability to unwind dsDNA. The XPD-DNA complex 
revealed that Arg584 significantly interacts with the DNA backbone. Furthermore 
ThermoFluor analysis demonstrated that both variants are properly folded so that 
the disease phenotype cannot be caused by partially unfolded protein. The Y425E 
variant is also located in this wedge-like region and displays a moderate DNA 
binding phenotype but a strong reduction in ATPase and helicase activity. Since 
this residue is disordered in the XPD-DNA complex structure no conclusions with 
respect to a DNA-complex formation for this residue can be derived from this 
structure. 
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Figure 5.4: Important Residues for DNA binding. (A) 
domain 4. The color code from figure 5.1 was maintained, and a transparent surface was added to 
provide a view of the groove were one DNA strand binds. All residues that may play an important 
role in DNA binding are indicated and lab
site. Color code from Figure 
representation. 
A bound sulfate between motor domain 1 and the arch domain indicates a putative 
phosphate binding site (Figure 5.4)
mutated and resulted in different phenotypes. The variants R88H, Y166A and 
K170A display reduced DNA binding and increased ATPase activity. The ability to 
unwind dsDNA however vari
helicase activity comparable to taXPD WT, Y166A displays no helicase activity 
and K170A shows an elevated helicase activity and 
negative regulator for helicase activity. Interestingl
difference in DNA binding to WT in all three mutants. Tyr166 and Tyr185 form a 
hydrophobic pocket which is a putative DNA 
to bind purine and pyrimidine bases. The Y166A/Y185A variant disp
DNA binding and ATPase activity, however the mutant did not over express well 
and was therefore not further pursued. F133A shows a similar phenotype as 
K170A with an increased helicase activity, however the ATPase activity is 
comparable to taXPD WT and the DNA binding ability is reduced. Arg118 is 
located near Phe133 on the surface of the FeS domain
-
A view towards helices 
eled. (Wolski et al. 2008)(B) Putative phosphate
4.6 with the FeS cluster and important residues shown in all
. Residues which interact with the sulfate were 
es greatly between the three variants. R88H has a 
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KD and a therefore reduced ATPase activity. The E107A is located directly in the 
pore and shows a reduced DNA binding ability but interestingly the ATPase and 
helicase activity are comparable to taXPD WT. 
The replacement of Arg112 (Arg88 in Thermoplasma acidophilum) to a histidine 
leads in humans to trichothiodystrophy. In contrast to the observation in Sulfolobus 
acidocaldarius(Rudolf et al. 2006) the R88H variant in Thermoplasma acidophilum 
displays no helicase phenotype. Furthermore R88H displays an elevated ATPase 
activity and a reduced DNA binding ability which is not surprising since Arg88 
points into a basic pocket which is proposed to be a DNA binding site. Arg88 
bridges the putative DNA binding site with the Cys113 cluster ligand. The 
exchange from arginine or lysine in Sulfolobus acidocaldarius to histidine shows a 
similar phenotype for the human protein and XPD fromSulfolobus acidocaldarius 
with an abolished helicase activity (Rudolf et al. 2006), (Dubaele et al. 2003). This 
observation can be explained by the loss of the FeS cluster indicating a more 
stable cluster in taXPD. 
Phe326 is partly located in the interface of the arch domain and the FeS domain. 
F326A displays a decreased helicase activity and a moderate DNA binding 
phenotype combined with an elevated ATPase activity. The phenylring of Phe326 
points towards the pore and could therefore be involved in pi-stacking interactions 
with DNA. The location of F326A may affect the flexibility between the arch 
domain and FeS domain which is necessary for helicase activity.Our XPD-DNA 
structure combined with the biochemical data identified regions for DNA binding. 
However it is not clear were DNA separation takes place. Due to the polarity of the 
translocated strand the DNA has to be separated behind the pore. Possible 
regions could be on the FeS domain close to the residues Phe133 and Arg118 or 
the arch domain with Phe326 could act as a wedge to separate DNA duplexes. 
 
5.4 The role of the FeS cluster 
The importance of the FeS cluster of XPD for helicase activity was investigated by 
Rudolf et al. (Rudolf et al. 2006). They could demonstrate that the helicase activity 
of XPD is abolished when it loses the FeS cluster (Rudolf et al. 2006). MutY is an 
FeS cluster containing DNA-glycosylase and was studied structurally in the 
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presence of DNA (Fromme et al. 2004). Therefore MutY was compared with XPD. 
For MutY it was shown that the FeS cluster is required for DNA binding and 
enzymatic activity (Porello et al. 1998). The superposition of the FeS cluster 
domains of both proteins revealed that the orientation of two conserved arginine 
residues (Arg88 in taXPD and Arg153 in MutY) is similar (Figure 5.5). For MutY it 
was shown that the neighboring Arg149 is located ideally to interact with the DNA 
backbone (Guan et al. 1998). Arg88 has a similar location as it points into a 
conserved pocket and thereby could interact with DNA. This pocket is furthermore 
a potential position for damage recognition. MutY contains an FeS cluster loop 
motif (Lukianova and David 2005) and the FeS cluster plays an important role in 
arranging the residues of this motif. A loop motif(residues 160-178) with a high 
density of positively charged residues is also found in the FeS domain of XPD and 
the FeS cluster could have a similar function in the positioning of the residues as 
in MutY (Lukianova and David 2005). 
 
 
Figure 5.5: Structural similarity to MutY. Side-by-side presentation of the 4Fe4S clusters of 
MutY and XPD after superposition. (A) Tow arginines (Arg149 and Arg153) are located in close 
proximity to the 4Fe4S cluster and point towards the DNA in MutY. (B) In XPD, Arg88 occupies a 
similar position as observed for the arginines in MutY. The helices surrounding the cluster have 
been labeled (Wolski et al. 2008). 
Boon et al. showed for MutY that DNA binding modulates the redox properties of 
the 4Fe4S cluster (Boon et al. 2003). Upon DNA binding the cluster is activated 
and thereby oxidized (Boal et al. 2009). It was proposed that via the two arginines 
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(Ar149 and Arg153) one electron could be transferred from the FeS cluster to the 
DNA (Boal and Barton 2005). This DNA-mediated charge transfer could 
accomplish rapid DNA scanning by several glycosylase molecules and they could 
thereby locate sites of damage (Boal et al. 2007). A similar mechanism seems 
unlikely in NER. However it is possible that DNA binding mediates the redox 
properties of the cluster and is therefore necessary for the damage verification 
step. This would suggest not only a structural but a functional role for the FeS 
cluster in XPD. Mutagenesis studies in Sulfolobus acidocaldarius(Rudolf et al. 
2006)revealed the importance of the FeS cluster coordinating cysteines. Single 
mutations of three of the four cysteines to serine leads to a loss of the FeS cluster 
and helicase activity is abolished. However it seems that the cluster in 
Thermoplasma acidophilum is more stable since the C92S variant contains a 
[4Fe4S]2+ cluster and C113S contains a stable [3Fe4S]1+ cluster. Helicase activity 
of the Thermoplasma acidophilum variants C92S and C113S has to be further 
investigated to verify if the enzyme activity is depending on the FeS cluster redox 
state. 
To obtain detailed insights into the FeS cluster properties they were further 
investigated by EPR analysis. Therefore XPD was treated with different oxidants 
and reducing agents. Interestingly, only Co-(phen)33+, Co-(5-Cl-phen)33+ and 
superoxide showed an effect on the cluster indicated by an oxidation to a 
[3Fe4S]1+ cluster. Whereas XPD was resistant to treatment by Ir(Cl)62-, 
ferricyanide, sodium dithionite, nitric oxide, peroxynitrite and hydrogen peroxide 
indicating a stable [4Fe4S]2+ cluster. The resistance to hydrogen peroxide 
suggests that XPD could be functional under oxidative stress conditions which 
corresponds to results for E.coli DinG (Ren et al. 2009). Furthermore EPR analysis 
of XPD in the presence of different DNA substrates and ATP was investigated. 
The FeS cluster is oxidized more readily in the presence of DNA which is further 
increased if ATP is added and the motor domains moveindicating that the cluster 
is more accessible for oxidants upon DNA binding and movement of the helicase 
domains. The importance of the cluster for helicase activity is supported by the our 
preliminary data that treatment of XPD with Co-(phen)33+, Co-(5-Cl-phen)33+, 
superoxide and sodium dithionite leads to a 50-fold reduction in helicase activity 
indicating that the [3Fe4S]1+cluster is not as capable for helicase activity as the 
[4Fe4S]2+cluster. This reduction is not due to unfolded protein since EPR 
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displayed no junk iron peaks which indicate the loss of the FeS cluster and CD 
spectroscopy showed that in the presence of oxidizing and reducing agents XPD 
is folded as the non treated sample. However it is not clear whether or not a 
[3Fe4S]1+ cluster can perform helicase activity whichhas to be further investigated 
by additional helicase and ATPase assays in the presence of different oxidizing 
agents. 
In the last few years more and more of iron-sulfur cluster containing proteins that 
interact with DNA or RNA have been reported. With respect to their functions 
these proteins can be divided into two groups (Ren et al. 2009). Group I contains 
the transcription or translation regulators for example the redox transcription factor 
SoxR (Ding et al. 1996), (Gaudu and Weiss 1996) and the repressor IscR 
(Schwartz et al. 2001). In this group of proteins the iron sulfur cluster acts as a 
specific signal sensor and modulates the interaction between protein and DNA and 
RNA (Ren et al. 2009). Group II consist of the iron-sulfur enzymes that chemically 
modify RNA or DNA. Members of this group are for example endonuclease III 
(Cunningham et al. 1989), (Boal et al. 2005), MutY (Porello et al. 1998), XPD and 
E.coli DinG helicase (Ren et al. 2009). It was demonstrated for the DinG helicase 
that its [4Fe4S]2+ cluster is redox-active and modulated by the second messenger 
molecule nitric oxide (Ren et al. 2009). NO is a physiological free radical involved 
in signal transduction in neuronal and cardiovascular systems (Ignarro 1999). 
Some studies revealed that chronic NO exposure is linked to carcinogenic 
processes and genomic instability (Gal and Wogan 1996), (Li et al. 2002). 
Mutations in the XPD gene lead to diseases which are associated with an increase 
of cancer incidence and aging phenotypes (Lehmann 2001), (Rudolf et al. 2006), 
(Fan et al. 2008), (Liu et al. 2008) it is therefore possible that chronic NO exposure 
may inactivate the FeS cluster of DNA repair enzymes like XPD and DinG. In this 
way this contributes to the initiation of the carcinogenic process and genomic 
instability (Gal and Wogan 1996), (Li et al. 2002), (Ren et al. 2009).However EPR 
studies revealed that XPD is resistant to oxidation by NO since no signal for a 
[3Fe4S]1+ cluster was obtained, but it has not been investigated so far if NO 
affects XPDs helicase activity. Thus it is unclear if XPD fulfillsa role in the NO 
signaling process. 
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5.5 Mechanistic conclusions from the XPD structure
In eukaryotes the initial damage recognition is achieved by the XPC/Rad23B 
complex. Afterwards TFIIH is recruited and with the combined action of XPD and 
XPB the DNA is unwound. 
needed whereas the helicase activity of XPD is necessary.
that Rad3 the yeast homolog of XPD is stalled at sites of damage during 
translocation in vivo(Naegeli et al. 1993
XPD from Ferroplasma acidarmanus
on the translocating strand 
ATPase activity is stimulated in the presence of 
2010).  
Figure 5.6: DNA separation and damage recognition. (A) 
motor domains colored in yellow and red and the FeS cluster domain colored in cyan. 
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In this process only the ATPase activity 
 Naegeli et al
). Furthermore it was demonstrated for 
 that it is stalled at lesions containing a CPD 
in vitro(Mathieu et al. 2010). Furthermore XPD’s 
a CPD lesion 
A minimal model of XPD with the two 
of XPB is 
. showed 
(Mathieu et al. 
(B) Possible 
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DNA separation site with XPD color coded as in Figure 4.6. Important residues and the FeS cluster 
are displayed in all bonds representation. (C) A minimal model of XPD with the two motor domains 
color-coded as in (A). A damage in the DNA is indicated by a pink star and possible incision sites 
are indicated by orange triangles. (D) Surface representation of taXPD color coded as in (A) with 
the narrow pocketcolored in dark blue. The DNA is shown in black with a modified base depicted in 
pink. 
UvrB is a homolog of XPD which was demonstrated to be involved in damage 
recognition. UvrB contains an β-hairpin which was shown to be essential for the 
damage recognition step (Truglio et al. 2006) and fulfills a similar function as XPD 
(Wang et al. 2006). Although XPD and UvrB display partially a high structural 
similarity XPD lacks a β-hairpin or similar feature. The question of damage 
verification in XPD therefore remains unsolved. The pore is with a diameter of 13 
Å too large to be a trap for modified DNA. A good candidate for damage 
verification is the narrow pocket at the FeS domain formed by residues Arg88, 
Tyr166 and Tyr185. The two variants R88H and Y166A display a slightly reduced 
DNA binding ability in combination with an ATPase activity as taXPD WT (R88H) 
or an increase in ATPase activity (Y166A). However they differ in the helicase 
activity. R88H shows a helicase activity as taXPD WT whereas Y166A displays no 
helicase activity. This pocket is sufficient in size to accommodate non-modified 
purine and pyrimidine bases which would be held in place by van der Waals 
interactions with the residues mentioned above. However, modified bases would 
be excluded from the pocket. The location of the possible damage recognition site 
in close proximity to the pore is further supported by the results of restriction 
protection assays (Mathieu et al. 2010). Mathieu et al. demonstrated that the DNA 
was cut 16 bases prior (5’-3’ direction) and 15 bases after the damage. DNA 
located close to the damage was protected from incision. Based on our structure 
and the polarity of the DNA it can be furthermore suggested that dsDNA unwinding 
takes place at the FeS domain and approximately 20-25 bases can be 
accommodated by XPD (Figure 5.6). This is further supported by biochemical data 
of the group of Maria Spies (Pugh et al. 2008) and in line with other DNA binding 
models (Liu et al. 2008). For eukaryotic NER it was shown that the excised 
fragment varies but the damage is always located 2-9 bases from the 3’-end 
(Wood 1999). Therefore the narrow pocket mentioned above would be an ideal 
position for damage verification (Figure 5.6). Furthermore Arg88 is located in close 
proximity to the FeS cluster and could in analogy to MutY bridge the distance 
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between the DNA and the FeS cluster (Fromme et al. 2004), (Boal and Barton 
2005) thus involving the cluster in the damage verification process. 
 
5.7 Final conclusions 
In this work the first crystal structure of apo XPD from Thermoplasma acidophilum 
was solved. The structure revealed a four-domain organization with two motor 
domains and two additional domains. The two auxiliary domains, the arch and the 
FeS domain, emerge from motor domain 1. Motor domain 1 together with the arch 
and FeS domain form a central pore. A ssDNA could pass through this central 
pore in close proximity to the FeS cluster as suggested by a DNA binding model. 
The suggested path of the DNA is supported by our structure of XPD with 4 bound 
DNA bases. It was possible to identify the polarity of DNA with the 5’-end pointing 
towards the solvent of domain 4 and the 3’end pointing towards the conserved 
path through the enzyme. Due to the high sequence homology to eukaryotic XPDs 
human mutations leading to xeroderma pigmentosum, Cockayne syndrome and 
trichothiodystrophy can be explained. Combined with a detailed mutagenic 
analysis important functional regions of the protein could be identified and 
important functions of the helicase during NER can be explained. These findings 
provide a basis for further analyses to understand the damage verification process 
in the NER pathway.  
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7 Apendix 
7.1 Abreviations 
(6-4)PP (6-4) pyrimidine-pyrimidone photoproduct 
AA Acrylamide 
Amp Ampicillin 
APS Ammonium peroxydisulfate 
BAA Bisacrylamide 
BER Base excsion repair 
BSA Bovine serum albumin 
CAK Cdk-activiating kinase 
Cam Chloramphenicol 
CD Circular dichroism 
Chl1 Chromatid cohesion in yeast 
CPD Cyclobutane pyrimidine dimers 
CS Cockayne Syndrome 
CSA Cockayne Syndrome A 
CSB Cockayne Syndrome B 
CV Column volume 
Da Dalton 
DDB Damaged DNA-binding protein 
DTT dithiothreitol 
DinG Damage-inducible G 
DNA Deoxyribonucleic acid 
DNase  desoxyribonuclease 
dsDNA Double stranded DNA 
E.coli Escherichia coli 
EDTA ethylenediaminetetraacetate 
EPR Electron paramagnetic resonance 
F Fluorescein 
FancJ Fanconi’s anemia complementation group J 
faXPD Ferroplasma acidarmanus XPD 
FeS Iron-sulfur 
GGR Global genome repair 
h hour 
IPTG Isopropyl-β-thiogalactoside 
LB Luria broth 
M molar 
MAD Multiwavelengt anomalous diffraction 
min minutes 
mL milliliter 
MMXD MMS19-MIP18-XPD 
MPD 2-Methyl-2,4-pentanediol 
MR Molecular Replacement 
MWCO Molecular weight cut off 
NER Nucleotide excision repair 
nm nanometer 
nM nanomolar 
OD Optical density 
PAGE Polyacrylamide gel electophoresis 
PCNA Proliferating cell nuclear antigen 
PCR Polymerase chain reaction 
PEG Polyethylenglycol 
RT Room temperature 
RTEL Regular of telomere length 
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saXPD Sulfolobus acidocaldarius XPD 
SDS Sodium dodecyl sulfate 
SEC Size exclusion chromatography 
SF2 Superfamily 2 
ssDNA Single stranded DNA 
taXPD Thermoplasma acidophilum XPD 
TCR Transcription coupled repair 
TEMED tetramethylethylenediamine 
TFIIH Transcriptionfactor II H 
TTD Trichothiodystrophy 
µL microliter 
µM micromolar 
UV ultraviolet 
WT Wild type 
XP Xeroderma Pigmentosum 
XP(B-G) Xeroderma pigmentosum complementation group (B-G) 
 
Aminoacids 
Alanine A 
Arginine R 
Asparagine N 
Asparatic acid D 
Cysteine C 
Glutamic acid E 
Glutamine Q 
Glycine G 
Histidine H 
Isoleucine I 
Leucine L 
Lysine K 
Methionine M 
Phenylalanine F 
Proline P 
Serine S 
Threonine T 
Tryptophan W 
Tyrosine Y 
Valine V 

 
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7.2 Table of table and figures 
Table 1.1 Distribution of selected DNA repair proteins in sequenced archaeal 
genomes 
Table 2.1 Instruments used in this work 
Table 2.2 Bacteria strains used in this work 
Table 2.3 Expression plasmids used in this work 
Table 2.4 Media for bacterial cell culture used in this work 
Table 2.5 Media additives used in this work 
Table 2.6 Enzymes used in this work 
Table 2.7 Nucleotides and Oligonucleotides used in this work 
Table 2.8 Oxidants and reducing agents used in this work 
Table 2.9 Crystallizationscreens used in this work 
Table 2.10 Software used in this work 
Table 3.1 Contents of the PCR reaction 
Table 3.2 PCR Program used in this work 
Table 4.1 Data collection and refinement statistics 
Table 4.2 Data collection and refinement statistics 
Table 4.3 DNA binding properties of XPD variants 
Table 4.4 Iron-sulfur cluster properties of taXPD 
Table 4.5 Iron-sulfur cluster properties of taXPD in presence of DNA 
Table 4.6 Iron-sulfur cluster properties of taXPD variants 
 
Figure 1.1 DNA lesions repaired by NER 
Figure 1.2 Model of the eukaryotic NER pathway 
Figure 1.3 Diagram representing the primary structure of taXPD 
Figure 1.4 Diseases caused by mutations in XPD 
Figure 1.5 Structure of common iron-sulfur centers and clusters 
Figure 3.1 Variation of the spin state energies as function of the applied magnetic 
field 
Figure 3.2 Block diagram of an EPR Spectrometer 
Figure 3.3 A schematic drawing of a protein crystallization phase diagram 
Figure 4.1 Purification of taXPD 
Figure 4.2 Purification of faXPD 
Figure 4.3 CD spectra of taXPD and faXPD 
Figure 4.4 Crystals of taXPD 
Figure 4.5 Crystals of faXPD 
Figure 4.6 Overall structure of taXPD  
Figure 4.7 FeS cluster 
Figure 4.8 Model of faXPD 
Figure 4.9 Electro-static surface potential of taXPD 
Figure 4.10 Hypothetical XPD-DNA Model 
Figure 4.11 The taXPD-DNA complex 
Figure 4.12 Sequence alignment 
Figure 4.13 Unfolding curves of taXPD WT and taXPD mutants 
Figure 4.14 DNA binding properties of taXPD variants 
Figure 4.15 KDs of taXPD variants 
Figure 4.16 ATPase activity of taXPD WT and variants 
Figure 4.17 Helicase activity of taXPD WT 
Figure 4.18 Helicase activity of taXPD variants 
Figure 4.19 DNA binding behavior of taXPD WT to different DNA substrates 
Figure 4.20 Comparison of DNA binding properties of taXPD and faXPD 
Figure 4.21 EPR spectra of taXPD WT 
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Figure 4.22 EPR spectra of taXPD variants
Figure 4.23 Helicase activity of taXPD WT in the presence of oxidizing and reducing 
agents 
Figure 4.24 CD spectra of taXPD treated with different agents
Figure 5.1 Superposition of taXPD and saXPD
Figure 5.2 Mutants leading to xeroderma pigmentosum, Cockayne syndrome and 
trichothiodystrophy
Figure 5.3 Zoom into the FeS cluster
Figure 5.4 Important Residues for DNA b
Figure 5.5 Structural s
Figure 5.6 DNA separation and damage recognition
Figure 7.1 Superposition of XPD with UvrB, NS3 and Hel308
 
7.3 Superposition of XPD with UvrB, NS3 and Hel308
 
Figure 7.1: Superposition of XPD with UvrB, NS3 and Hel308. 
(A) XPD was superimposed with UvrB shown in grey. The two RecA
superimpose, whereas the remainder of the two protein models share no structural homology. 
superposition of XPD and NS3 with NS3 colored i
superposition of the motor domains of XPD (yellow and red), NS3 (blue) and Hel308 (light blue) 
using the first RecA domain (domain 1) as the pivot point.
 
 
	(4
 
 
 
 
 domain 
inding 
imilarity to MutY 
 
 
 
XPD iscolor-
-like domains (yellow and red) 
n blue which lead to an rmsd of 3 Å. 
 (Wolski et al. 2008) 
 
coded as in figure X, 
(B) 
(C) 
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7.4 Sequences of constructs 
 
XPD from Ferroplasma acidarmanus(pET28a derived from N. Mathieu) 
MEKFTPREWQDALISTVSKNLEEKNKIAIEAPTGSGKTSFILYLAFITGKKLIYLTRTHNEFT
RLYEDNQKYFNIPALYLYGKSKLCPLKERWYDSEDDGQKNVCKGCPLKDKTIKLDLKNIR
SPESFLEDIEADSTELIRQDVESKALGRDTKGNLVTIKKENVKSYCPYYSVRSNMADAQII
AMTYNYLLNPSIRFNVFHGTEGEEMIDLNECYIVFDEAHNLDSVIENFGRTLQIKTVEKAID
MLVKDFPIETYNSYDRIEANLMLENLLSNMSSTRGTDSLKLFKFSNDFASRIANLESLRTF
SDEFEEKNENRPLNKRSRNYLENVYNFLYDYQRMENGSVYSTINNPEKKDLKLKLMYYD
TSGYLSFLRDNSVIFMSGTMPSVDHISKVWNMENVLYLKVDSIFKNAGGLKQYHIVNGYT
TLGRYRENLDDWAEMLRKYMQFAIDVYSKSDKSVLVAVPSYRILFGDTYTKTPGIGNYLP
ESMRANCVFENKKISYSYIEKKAKERKIIIFSVHGGKLLEGIQLVNRGKSLISDVIIAGLPLIPL
DDYRKDKIKYLEKVLKKNAYNLLYYEFALIKVKQAAGRSTRSPEDTSSIWLCDDRFDEPF
WQSNLLPNTK 
 
ATGGAAAAATTTACCCCCAGGGAATGGCAGGATGCCCTGATAAGCACCGTATCAAAA
AACCTTGAGGAGAAAAACAAAATTGCCATAGAGGCACCTACCGGTTCCGGAAAGACC
AGCTTCATACTATATCTGGCTTTTATTACAGGGAAGAAATTAATTTACCTTACCAGAAC
ACATAATGAATTCACGAGGCTTTATGAGGATAACCAGAAATATTTCAACATACCCGCT
TTATATTTATATGGAAAAAGCAAATTATGCCCGCTTAAAGAGAGGTGGTACGACTCAG
AAGATGATGGGCAGAAAAATGTATGCAAAGGGTGCCCCTTGAAGGATAAAACCATAA
AGCTTGATCTGAAAAATATAAGGAGCCCGGAGAGTTTTCTGGAAGACATAGAAGCTG
ATTCTACGGAACTTATCAGGCAGGATGTGGAATCAAAGGCCCTCGGAAGGGATACAA
AGGGGAATCTTGTTACAATCAAGAAAGAAAATGTAAAATCCTATTGCCCATATTATTCT
GTGCGGTCCAACATGGCAGATGCACAGATAATAGCCATGACATATAACTATCTGTTAA
ATCCATCAATACGGTTCAATGTTTTTCATGGCACCGAAGGGGAAGAGATGATTGACC
TTAATGAATGCTATATAGTTTTTGATGAAGCACATAACCTGGATTCTGTAATAGAAAAT
TTTGGCCGGACGCTGCAGATAAAAACAGTAGAGAAGGCAATTGATATGCTTGTAAAG
GATTTTCCAATTGAAACTTATAATTCATATGATAGGATTGAAGCAAATTTGATGCTTGA
AAATCTTCTGTCCAACATGAGCTCAACAAGGGGAACCGATAGTCTCAAGCTATTCAAA
TTTTCTAATGATTTTGCATCAAGGATTGCAAACCTTGAATCACTCAGGACATTCAGTG
ATGAATTTGAAGAAAAAAACGAAAACAGGCCATTGAATAAGAGAAGCAGGAATTACCT
GGAAAACGTTTACAATTTTCTCTATGATTACCAGAGGATGGAAAATGGTTCAGTGTAC
TCCACTATCAATAATCCGGAAAAAAAAGATTTAAAACTTAAATTGATGTATTATGATAC
ATCCGGCTATCTTTCATTTTTACGGGATAACTCTGTTATTTTTATGTCCGGGACAATGC
CATCTGTAGACCATATCTCAAAGGTATGGAATATGGAAAATGTCCTGTACCTGAAAGT
TGACAGCATATTCAAAAACGCCGGCGGGCTAAAGCAATACCATATAGTTAACGGTTA
TACAACTCTGGGACGTTACCGCGAAAACCTGGATGATTGGGCTGAAATGCTCAGAAA
ATATATGCAGTTTGCCATTGATGTTTACTCAAAATCGGATAAAAGTGTACTTGTTGCTG
TCCCCTCATATCGCATACTTTTTGGCGACACCTATACAAAAACACCAGGCATAGGCAA
TTACCTGCCAGAAAGTATGAGGGCAAACTGTGTATTCGAAAACAAGAAAATTTCTTAT
TCCTATATAGAAAAGAAAGCGAAGGAGAGAAAAATAATTATTTTTTCTGTACACGGTG
GCAAACTTCTTGAGGGCATACAGCTGGTTAACCGGGGAAAAAGCCTGATTAGCGATG
TAATCATTGCAGGGCTTCCCCTGATACCCCTTGATGATTACAGAAAGGATAAAATAAA
ATATCTTGAAAAAGTGCTGAAAAAAAATGCATACAATCTGCTCTATTATGAGTTTGCG
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CTTATCAAAGTAAAACAGGCAGCAGGCAGATCTACAAGGTCTCCAGAGGATACTTCC
AGCATATGGCTCTGTGATGACAGGTTTGATGAGCCTTTCTGGCAATCCAATTTGCTTC
CTAACACAAAATAACTCGAG 
 
Restrictionenzymes used for cloning NdeI and Xho 
 
XPD Thermoplasma acidophilum(pET16b, T4, residues 23-602) 
 
Amino acid sequence: 
MQKSYGVALESPTGSGKTIMALKSALQYSSERKLKVLYLVRTNSQEEQVIKELRSLSSTM
KIRAIPMQGRVNMCILYRMVDDLHEINAESLAKFCNMKKREVMAGNEAACPYFNFKIRSD
ETKRFLFDELTAEEFYDYGERNNVCPYESMKAALPDADIVIAPYAYFLNRSVAEKFLSHW
GVSRNQIVIILDEAHNLPDIGRSIGSFRISVESLNRADREAQAYGDPELSQKIHVSDLIEMIR
SALQSMVSERCGKGDVRIRFQEFMEYMRIMNKRSEREIRSLLNYLYLFGEYVENEKEKV
GKVPFSYCSSVASRIIAFSDQDEEKYAAILSPEDGGYMQAACLDPSGILEVLKESKTIHMS
GTLDPFDFYSDITGFEIPFKKIGEIFPPENRYIAYYDGVSSKYDTLDEKELDRMATVIEDIILK
VKKNTIVYFPSYSLMDRVENRVSFEHMKEYRGIDQKELYSMLKKFRRDHGTIFAVSGGRL
SEGINFPGNELEMIILAGLPFPRPDAINRSLFDYYERKYGKGWEYSVVYPTAIKIRQEIGRLI
RSAEDTGACVILDKRAGQFRKFIPDMKKTSDPASDIYNFFISAQAREKYGA 
 
 
 
XPD Thermoplasma acidophilum (pET16b, T3; residues 1-602) 
 
Amino acid sequence: 
MYENRQYQVEAIDFLRSSLQKSYGVALESPTGSGKTIMALKSALQYSSERKLKVLYLVRT
NSQEEQVIKELRSLSSTMKIRAIPMQGRVNMCILYRMVDDLHEINAESLAKFCNMKKREV
MAGNEAACPYFNFKIRSDETKRFLFDELPTAEEFYDYGERNNVCPYESMKAALPDADIVI
APYAYFLNRSVAEKFLSHWGVSRNQIVIILDEAHNLPDIGRSIGSFRISVESLNRADREAQ
AYGDPELSQKIHVSDLIEMIRSALQSMVSERCGKGDVRIRFQEFMEYMRIMNKRSEREIR
SLLNYLYLFGEYVENEKEKVGKVPFSYCSSVASRIIAFSDQDEEKYAAILSPEDGGYMQA
ACLDPSGILEVLKESKTIHMSGTLDPFDFYSDITGFEIPFKKIGEIFPPENRYIAYYDGVSSK
YDTLDEKELDRMATVIEDIILKVKKNTIVYFPSYSLMDRVENRVSFEHMKEYRGIDQKELY
SMLKKFRRDHGTIFAVSGGRLSEGINFPGNELEMIILAGLPFPRPDAINRSLFDYYERKYG
KGWEYSVVYPTAIKIRQEIGRLIRSAEDTGACVILDKRAGQFRKFIPDMKKTSDPASDIYNF
FISAQAREKYGA 
atgtacgagaacaggcagtaccaggtggaggccatcgattttctcaggagttctttgcagaaaagctacggcgtggcacttga
atctccaaccggttccggcaagaccatcatggcattgaaatctgccctgcagtattcaagtgaaaggaagctcaaggttctgt
accttgtccgcaccaattcgcaggaggaacaggttataaaggaattgagatctctttcatccacgatgaagatccgcgcaata
ccaatgcagggcagggtcaatatgtgcatactctacaggatggttgacgatctgcacgagataaatgcagaatctcttgcaaa
attctgcaacatgaagaagcgtgaggtcatggccggaaatgaggctgcatgcccgtacttcaacttcaagataagatccgat
gaaacgaagaggtttcttttcgacgagctgccgactgcggaggaattttacgattatggggaaaggaacaacgtgtgccctta
tgaaagcatgaaggcagcactgccagatgcagacattgttatagcaccttatgcatattttctcaacaggtccgtggcagaga
agtttctcagccactggggcgtctcaagaaaccagatagtgataatactggatgaagcgcacaacctgccggatataggca
gatccataggatccttcaggatatctgtggaatcgctgaacagagcagacagggaggctcaggcatacggtgatccagagc
tgtcgcagaagatccatgtttccgatctgatagagatgatcagaagtgctttgcagagcatggtcagcgagagatgcgggaa
gggcgacgtcaggataaggttccaggaattcatggaatatatgaggataatgaacaagaggagcgagagagaaataaga
tcgctgctgaactatctctatctcttcggcgaatacgtggaaaacgagaaggaaaaggtgggcaaggtacctttcagttattgct
cgtccgttgccagcaggatcatcgcattctctgaccaggatgaggagaagtacgcggccatactttcgccggaagacggcg
gatatatgcaggcggcctgccttgatccgtctggaatactggaggtgctgaaggaatccaagacgatacacatgtccggaac
gcttgatcctttcgatttctattccgacatcaccggtttcgagattcctttcaagaagataggcgaaatatttcctcctgagaacag
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atacattgcgtattacgatggggtgtcatcaaaatacgacacgctggatgaaaaggaactggacagaatggcgacggtgat
agaggatataatactgaaggtgaagaagaacaccatagtgtactttccatcatattcgctcatggacagggttgagaacagg
gtatcattcgaacacatgaaggagtacaggggcatagaccagaaggaactgtactccatgcttaagaaattcaggagggat
catggtacaattttcgcagtatctggcggaaggctttctgaaggcataaattttccgggaaacgaactggagatgataatactc
gcgggcctgcctttcccgaggccggacgccatcaacagatcgctgtttgactactatgagaggaaatacggcaagggctgg
gaatacagcgtcgtgtatccaacggccataaagataaggcaggagatagggaggctcataaggagtgcggaagatacag
gcgcctgcgtgatcctggacaagagggccggccagttcaggaaattcatacctgatatgaagaagacgtcggatccggcat
cggatatatacaattttttcatatctgcgcaggcacgcgaaaaatatggggcctga 
 
 
XPD Thermoplasma acidophilum(pBadM11, residues 1-602; derived from Florian 
Rohleder)  
MNENRQYQVEAIDFLRSSLQKSYGVALESPTGSGKTIMALKSALQYSSERKLKVLYLVRT
NSQEEQVIKELRSLSSTMKIRAIPMQGRVNMCILYRMVDDLHEINAESLAKFCNMKKREV
MAGNEAACPYFNFKIRSDETKRFLFDELPTAEEFYDYGERNNVCPYESMKAALPDADIVI
APYAYFLNRSVAEKFLSHWGVSRNQIVIILDEAHNLPDIGRSIGSFRISVESLNRADREAQ
AYGDPELSQKIHVSDLIEMIRSALQSMVSERCGKGDVRIRFQEFMEYMRIMNKRSEREIR
SLLNYLYLFGEYVENEKEKVGKVPFSYCSSVASRIIAFSDQDEEKYAAILSPEDGGYMQA
ACLDPSGILEVLKESKTIHMSGTLDPFDFYSDITGFEIPFKKIGEIFPPENRYIAYYDGVSSK
YDTLDEKELDRMATVIEDIILKVKKNTIVYFPSYSLMDRVENRVSFEHMKEYRGIDQKELY
SMLKKFRRDHGTIFAVSGGRLSEGINFPGNELEMIILAGLPFPRPDAINRSLFDYYERKYG
KGWEYSVVYPTAIKIRQEIGRLIRSAEDTGACVILDKRAGQFRKFIPDMKKTSDPASDIYNF
FISAQAREKYGA 
 
ctgttggacagaaaaaaaggtttccatccgcttctaagtggaactatgaggattgctaatattcattaaccgggtcagcatctttc
acagaggatggacgagaacaggcagtaccaggtggaggccatcgattttctcaggagttctttgcagaaaagctacggcgt
ggcacttgaatctccaaccggttccggcaagaccatcatggcattgaaatctgccctgcagtattcaagtgaaaggaagctca
aggttctgtaccttgtccgcaccaattcgcaggaggaacaggttataaaggaattgagatctctttcatccacgatgaagatcc
gcgcaataccaatgcagggcagggtcaatatgtgcatactctacaggatggttgacgatctgcacgagataaatgcagaatc
tcttgcaaaattctgcaacatgaagaagcgtgaggtcatggccggaaatgaggctgcatgcccgtacttcaacttcaagataa
gatccgatgaaacgaagaggtttcttttcgacgagctgccgactgcggaggaattttacgattatggggaaaggaacaacgt
gtgcccttatgaaagcatgaaggcagcactgccagatgcagacattgttatagcaccttatgcatattttctcaacaggtccgtg
gcagagaagtttctcagccactggggcgtctcaagaaaccagatagtgataatactggatgaagcgcacaacctgccggat
ataggcagatccataggatccttcaggatatctgtggaatcgctgaacagagcagacagggaggctcaggcatacggtgat
ccagagctgtcgcagaagatccatgtttccgatctgatagagatgatcagaagtgctttgcagagcatggtcagcgagagat
gcgggaagggcgacgtcaggataaggttccaggaattcatggaatatatgaggataatgaacaagaggagcgagagag
aaataagatcgctgctgaactatctctatctcttcggcgaatacgtggaaaacgagaaggaaaaggtgggcaaggtaccttt
cagttattgctcgtccgttgccagcaggatcatcgcattctctgaccaggatgaggagaagtacgcggccatactttcgccgga
agacggcggatatatgcaggcggcctgccttgatccgtctggaatactggaggtgctgaaggaatccaagacgatacacat
gtccggaacgcttgatcctttcgatttctattccgacatcaccggtttcgagattcctttcaagaagataggcgaaatatttcctcct
gagaacagatacattgcgtattacgatggggtgtcatcaaaatacgacacgctggatgaaaaggaactggacagaatggc
gacggtgatagaggatataatactgaaggtgaagaagaacaccatagtgtactttccatcatattcgctcatggacagggttg
agaacagggtatcattcgaacacatgaaggagtacaggggcatagaccagaaggaactgtactccatgcttaagaaattc
aggagggatcatggtacaattttcgcagtatctggcggaaggctttctgaaggcataaattttccgggaaacgaactggagat
gataatactcgcgggcctgcctttcccgaggccggacgccatcaacagatcgctgtttgactactatgagaggaaatacggc
aagggctgggaatacagcgtcgtgtatccaacggccataaagataaggcaggagatagggaggctcataaggagtgcgg
aagatacaggcgcctgcgtgatcctggacaagagggccggccagttcaggaaattcatacctgatatgaagaagacgtcg
gatccggcatcggatatatacaattttttcatatctgcgcaggcacgcgaaaaatatggggcctgaaccctgcgtggaaaacg
ttttatgcctgttttgatt 
 
Restrictionenyzmes used for cloning NcoI and HindIII 
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7.5 Primer for mutagenesis 
R567W_fwd: ggc agg aga tag ggt ggc tca taa gga gtg c 
R567W_rev: gca ctc ctt atg agc cac cct atc tcc tgc c 
XPD_R118A_fwd; gca aca tga aga agg ctg agg tca tgg 
XPD_R118A_rev; cca tga cct cag cct tct tca tgt tgc 
XPD_R584A_fwd;gat ctt gga caa ggc ggc cgg cca gtt c 
XPD_R584A_rev; gaa ctg gcc ggc cgc ctt gtc cag gat c 
XPD_Y545S_fwd; gag agg aaa tcc ggc aag ggc tgg g 
XPD_Y545S_rev; cca gcc ctt gcc gga ttt cct ctc 
XPD_R567A_fwd; gga gat agg ggc gct cat aag gag tgc 
XPD_R567A_rev; gca ctc ctt atg agc gcc cct atc tcc 
XPD_Y185V_fwd; gca cct tat gca gtg ttt ctc aac agg 
XPD_Y185V_rev; cct gtt gag aaa cac tgc ata agg tgc 
XPD_Y182V_fwd; gtt ata gca cct gtg gca tat ttt ctc 
XPD_Y182V_rev; gag aaa ata tgc cac agg tgc tat aac 
XPD_F133A_fwd; ccg tac ttc aac gcc aag ata aga tcc g 
XPD_F133A_rev; cgg atc tta tct tgg cgt tga agt acg g 
XPD_R136A_fwd; ctt caa gat agc atc cga tga aac g 
XPD_R136A_rev; cgt ttc atc gga tgc tat ctt gaa g 
XPD_K134A_fwd; cgt act tca act tcg cga taa gat ccg atg 
XPD_K134A_rev; cat cgg atc tta tcg cga agt tga agt acg 
XPD_M115R_fwd; gca aaa ttc tgc aac cgg aag aag cgt gag 
XPD_M115R_rev; ctc acg ctt ctt ccg gtt gca gaa ttt tgc 
XPD_V324R_fwd; ggt ggg caa gcg acc ttt cag tta ttg c 
XPD_V324R_rev; gca ata act gaa agg tcg ctt gcc cac c 
XPD_E319R_fwd; cgt gga aaa cga gaa gcg aaa ggt ggg caa g 
XPD_E319R_rev; ctt gcc cac ctt tcg ctt ctc gtt ttc cac g 
XPD_R88M_fwd; cca atg cag ggc atg gtc aat atg 
XPD_R88M_rev; cat att gac cat gcc ctg cat tgg 
XPD_P530E_fwd; gcc ttt ccc gag gga gga cgc cat c 
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XPD_P530E_rev; gat ggc gtc ctc cct cgg gaa agg c 
XPD_Y46A_fwd; tgc cct gca ggc ttc aag tga aag g 
XPD_Y46A_rev; cct tta ctt gaa gcc tgc agg gcc ag 
XPD_R88A_fwd; cca atg cag ggc gcg gtc aat atg tgc 
XPD_R88A_rev; cac ata ttg acc gcg ccc tgc att gg 
XPD_K170E_fwd; ctt atg aaa gca tgg agg cag cac tgc cag 
XPD_K170E_rev; ctg gca gtg ctg cct cca tgc ttt cat aag g 
XPD_C148S_neu_fwd; gga aca acg tgt ccc ctt atg aaa gc 
XPD_C148S_neu_rev; gct ttc ata agg gga cac gtt gtt cc 
XPD_E107A_fwd; cga gat aaa tgc agc atc tct tgc 
XPD_E107A_rev; gca aga gat gct gca ttt atc tcg 
XPD_E315A_fwd; ggc gaa tac gtg gca aac gag aag g 
XPD_E315A_rev; cct tct cgt ttg cca cgt att cgc c 
XPD_Y540S/Y545S_rev; ccc ttg ccg gat ttc ctc tca tag gtg tc 
XPD_Y540S/Y545S_fwd; gac tcc tat gag agg aaa tcc ggc aag gg 
XPD_F538S_fwd; tca aca gat cgc tgt ctg act  
XPD_F538S_rev; agt cag aca gcg atc tgt tg 
XPD_W549S_fwd; ggc aag ggc tcg gaa tac agc g 
XPD_W549S_rev; cgc tgt att ccg agc cct tg 
C73S fwd; cag ggt caa tat gtc cat ac 
C73S rev; gta tgg aca tat tga ccc tg 
C94S fwd; ctt gca aaa ttc tcc aac atg 
C94S rev; cat gtt gga gaa ttt tgc aag 
C108S fwd; tga ggc tgc atc ccc gta ctt caa c 
C108S rev; gtt gaa gta cgg gga tgc agc ctc a 
neu_Y545S/W549S_fwd; tat gag agg aaa tcc ggc aag ggc tcg gaa tac 
neu_Y545S/W549S_rev; gta ttc cga gcc ctt gcc gga ttt cct ctc ata 
neu_K170A_fwd; gcc ctt atg aaa gca tgg cgg cag cac tg 
neu_K170A_rev; cag tgc tgc cgc cat gct ttc ata agg gc 
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neu_Y185A_fwd; gtt ata gca cct tat ggc agc ttt tct caa c 
neu_Y185A_rev; gtt gag aaa agc tgc cat aag gtg cta taa c 
neu_F226A_fwd; ggc aga tcc ata gga tcc gcc agg aat atc tg 
neu_F226A_rev; cag ata ttc ctg gcg gat cct atg gat ctg cc 
XPD_ R59A_fwd; ctt gtc gcc acc aat tcg 
XPD_ R59A_rev; gaa ttg gtg gcg aca agg 
XPD_R59E_rev; gaa ttg gtc tcg aca agg 
XPD_R88A_fwd; gca ggg cgc ggt caa tat g 
XPD_R88A_rev; cat att gac cgc gcc ctg c 
XPD_R88H_fwd; gca ggg cca cgt caa tat g 
XPD_R88H_rev; cat att gac gtg gcc ctg c 
XPD_F326A_fwd; caa ggt acc tgc cag tta ttg 
XPD_F326A_rev; caa taa ctg gca ggt acc ttg 
XPD_Y425E_fwd; gtc atc aaa aga gga cac gc 
XPD_Y425E_rev; gcg tgt cct ctt ttg atg ac 
XPD_F538S/Y540S_fwd; gat cgc tgt ctg act cct atg a 
XPD_F538S/Y540S_rev; tca tag gag tca gac agc gat c 
XPD_D582N_fwd; gtg atc ctg aac aag agg 
XPD_D582N_rev; ccc tct tgt tca gga tca c 
XPD_R584E_fwd; gga caa gca ggc cgg cca g 
XPD_R584E_rev; ctg gcc ggc ctg ctt gtc c 
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